Testing the Role of DNA Released From Tumor Cells Into the Blood in Guiding the Use of Immunotherapy After Surgical Removal of the Bladder, Kidney, Ureter, and Urethra for Urothelial Cancer Treatment, MODERN Study

Abroad (travel likely)RecruitingPHASE2, PHASE3

Conditions

Muscle Invasive Bladder Urothelial Carcinoma · Muscle Invasive Renal Pelvis Urothelial Carcinoma · Muscle Invasive Ureter Urothelial Carcinoma · Muscle Invasive Urethral Urothelial Carcinoma · Stage II Bladder Urothelial Carcinoma AJCC v6 and v7 · Stage III Bladder Urothelial Carcinoma AJCC v6 and v7 · Stage IV Bladder Urothelial Carcinoma AJCC v7

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations
  • Cancer Center at Saint Joseph's, Phoenix, Arizona, United States

    Contact: Study coordinator (Site Public Contact) · ResearchInstituteInquiries@CommonSpirit.org · 720-874-1881
    Contact: Principal Investigator (Shahzad Siddique)
  • Mayo Clinic Hospital in Arizona, Phoenix, Arizona, United States

    Contact: Study coordinator (Site Public Contact) · 855-776-0015
    Contact: Principal Investigator (Arnab Basu)
  • University of Arizona Cancer Center-Orange Grove Campus, Tucson, Arizona, United States

  • Banner University Medical Center - Tucson, Tucson, Arizona, United States

    Contact: Study coordinator (Site Public Contact) · UACC-IIT@uacc.arizona.edu
    Contact: Principal Investigator (Edward P. Gelmann)
  • University of Arizona Cancer Center-North Campus, Tucson, Arizona, United States

    Contact: Study coordinator (Site Public Contact) · UACC-IIT@uacc.arizona.edu
    Contact: Principal Investigator (Edward P. Gelmann)
  • Highlands Oncology Group - Fayetteville, Fayetteville, Arkansas, United States

    Contact: Study coordinator (Site Public Contact) · research@hogonc.com · 479-872-8100
    Contact: Principal Investigator (Joseph T. Beck)
  • Highlands Oncology Group - Rogers, Rogers, Arkansas, United States

    Contact: Study coordinator (Site Public Contact) · research@hogonc.com · 479-872-8130
    Contact: Principal Investigator (Joseph T. Beck)
  • Highlands Oncology Group, Springdale, Arkansas, United States

    Contact: Study coordinator (Site Public Contact) · research@hogonc.com · 479-872-8130
    Contact: Principal Investigator (Joseph T. Beck)
  • Kaiser Permanente-Anaheim, Anaheim, California, United States

    Contact: Study coordinator (Site Public Contact) · clinical.trials@kp.org · 800-398-3996
    Contact: Principal Investigator (Helen H. Moon)
  • Kaiser Permanente-Baldwin Park, Baldwin Park, California, United States

    Contact: Study coordinator (Site Public Contact) · clinical.trials@kp.org · 800-398-3996
    Contact: Principal Investigator (Helen H. Moon)
  • Kaiser Permanente-Bellflower, Bellflower, California, United States

    Contact: Study coordinator (Site Public Contact) · clinical.trials@kp.org · 800-398-3996
    Contact: Principal Investigator (Helen H. Moon)
  • Kaiser Permanente Dublin, Dublin, California, United States

    Contact: Study coordinator (Site Public Contact) · 877-642-4691
    Contact: Principal Investigator (Andrea L. Harzstark)
  • Kaiser Permanente-Fontana, Fontana, California, United States

    Contact: Study coordinator (Site Public Contact) · clinical.trials@kp.org · 800-398-3996
    Contact: Principal Investigator (Helen H. Moon)
  • Kaiser Permanente-Fremont, Fremont, California, United States

    Contact: Study coordinator (Site Public Contact) · Kpoct@kp.org · 877-642-4691
    Contact: Principal Investigator (Andrea L. Harzstark)
  • Kaiser Permanente Fresno Orchard Plaza, Fresno, California, United States

    Contact: Study coordinator (Site Public Contact) · 833-574-2273
    Contact: Principal Investigator (Andrea L. Harzstark)
  • Kaiser Permanente-Fresno, Fresno, California, United States

    Contact: Study coordinator (Site Public Contact) · Kpoct@kp.org · 877-642-4691
    Contact: Principal Investigator (Andrea L. Harzstark)
  • Kaiser Permanente South Bay, Harbor City, California, United States

    Contact: Study coordinator (Site Public Contact) · clinical.trials@kp.org · 800-398-3996
    Contact: Principal Investigator (Helen H. Moon)
  • Kaiser Permanente-Irvine, Irvine, California, United States

    Contact: Study coordinator (Site Public Contact) · clinical.trials@kp.org · 800-398-3996
    Contact: Principal Investigator (Helen H. Moon)
  • UC San Diego Moores Cancer Center, La Jolla, California, United States

    Contact: Study coordinator (Site Public Contact) · cancercto@ucsd.edu · 858-822-5354
    Contact: Principal Investigator (Tyler Stewart)
  • Keck Medicine of USC Koreatown, Los Angeles, California, United States

  • Kaiser Permanente Los Angeles Medical Center, Los Angeles, California, United States

    Contact: Study coordinator (Site Public Contact) · clinical.trials@kp.org · 800-398-3996
    Contact: Principal Investigator (Helen H. Moon)
  • Los Angeles General Medical Center, Los Angeles, California, United States

  • USC / Norris Comprehensive Cancer Center, Los Angeles, California, United States

  • Kaiser Permanente West Los Angeles, Los Angeles, California, United States

    Contact: Study coordinator (Site Public Contact) · clinical.trials@kp.org · 800-398-3996
    Contact: Principal Investigator (Helen H. Moon)
  • UCLA / Jonsson Comprehensive Cancer Center, Los Angeles, California, United States

    Contact: Study coordinator (Site Public Contact) · 888-798-0719
    Contact: Principal Investigator (Alexandra Drakaki)
  • Kaiser Permanente- Modesto MOB II, Modesto, California, United States

    Contact: Study coordinator (Site Public Contact) · 877-642-4691
    Contact: Principal Investigator (Andrea L. Harzstark)
  • Kaiser Permanente-Modesto, Modesto, California, United States

    Contact: Study coordinator (Site Public Contact) · Kpoct@kp.org · 877-642-4691
    Contact: Principal Investigator (Andrea L. Harzstark)
  • USC Norris Oncology/Hematology-Newport Beach, Newport Beach, California, United States

  • Kaiser Permanente-Oakland, Oakland, California, United States

    Contact: Study coordinator (Site Public Contact) · Kpoct@kp.org · 877-642-4691
    Contact: Principal Investigator (Andrea L. Harzstark)
  • Kaiser Permanente-Ontario, Ontario, California, United States

    Contact: Study coordinator (Site Public Contact) · clinical.trials@kp.org · 800-398-3996
    Contact: Principal Investigator (Helen H. Moon)
  • Stanford Cancer Institute Palo Alto, Palo Alto, California, United States

    Contact: Study coordinator (Site Public Contact) · ccto-office@stanford.edu · 650-498-7061
    Contact: Principal Investigator (Ali R. Khaki)
  • Kaiser Permanente - Panorama City, Panorama City, California, United States

    Contact: Study coordinator (Site Public Contact) · clinical.trials@kp.org · 800-398-3996
    Contact: Principal Investigator (Helen H. Moon)
  • Kaiser Permanente-Riverside, Riverside, California, United States

    Contact: Study coordinator (Site Public Contact) · clinical.trials@kp.org · 800-398-3996
    Contact: Principal Investigator (Helen H. Moon)
  • Kaiser Permanente-Roseville, Roseville, California, United States

    Contact: Study coordinator (Site Public Contact) · Kpoct@kp.org · 877-642-4691
    Contact: Principal Investigator (Andrea L. Harzstark)
  • Kaiser Permanente Downtown Commons, Sacramento, California, United States

    Contact: Study coordinator (Site Public Contact) · kpoct@kp.org · 877-642-4691
    Contact: Principal Investigator (Andrea L. Harzstark)
  • University of California Davis Comprehensive Cancer Center, Sacramento, California, United States

    Contact: Study coordinator (Site Public Contact) · 916-734-3089
    Contact: Principal Investigator (Mamta Parikh)
  • Kaiser Permanente-South Sacramento, Sacramento, California, United States

    Contact: Study coordinator (Site Public Contact) · Kpoct@kp.org · 877-642-4691
    Contact: Principal Investigator (Andrea L. Harzstark)
  • Kaiser Permanente-San Diego Zion, San Diego, California, United States

    Contact: Study coordinator (Site Public Contact) · clinical.trials@kp.org · 800-398-3996
    Contact: Principal Investigator (Helen H. Moon)
  • Kaiser Permanente-San Francisco, San Francisco, California, United States

    Contact: Study coordinator (Site Public Contact) · Kpoct@kp.org · 877-642-4691
    Contact: Principal Investigator (Andrea L. Harzstark)
  • Kaiser Permanente-Santa Teresa-San Jose, San Jose, California, United States

    Contact: Study coordinator (Site Public Contact) · Kpoct@kp.org · 877-642-4691
    Contact: Principal Investigator (Andrea L. Harzstark)
  • Kaiser Permanente San Leandro, San Leandro, California, United States

    Contact: Study coordinator (Site Public Contact) · Kpoct@kp.org · 877-642-4691
    Contact: Principal Investigator (Andrea L. Harzstark)
  • Kaiser Permanente-San Marcos, San Marcos, California, United States

    Contact: Study coordinator (Site Public Contact) · clinical.trials@kp.org · 800-398-3996
    Contact: Principal Investigator (Helen H. Moon)
  • Kaiser San Rafael-Gallinas, San Rafael, California, United States

    Contact: Study coordinator (Site Public Contact) · Kpoct@kp.org · 877-642-4691
    Contact: Principal Investigator (Andrea L. Harzstark)
  • Kaiser Permanente Medical Center - Santa Clara, Santa Clara, California, United States

    Contact: Study coordinator (Site Public Contact) · Kpoct@kp.org · 877-642-4691
    Contact: Principal Investigator (Andrea L. Harzstark)
  • Saint John's Cancer Institute, Santa Monica, California, United States

    Contact: Study coordinator (Site Public Contact) · 310-582-7448
    Contact: Principal Investigator (Przemyslaw W. Twardowski)
  • Kaiser Permanente-Santa Rosa, Santa Rosa, California, United States

    Contact: Study coordinator (Site Public Contact) · Kpoct@kp.org · 877-642-4691
    Contact: Principal Investigator (Andrea L. Harzstark)
  • Kaiser Permanente-South San Francisco, South San Francisco, California, United States

    Contact: Study coordinator (Site Public Contact) · Kpoct@kp.org · 877-642-4691
    Contact: Principal Investigator (Andrea L. Harzstark)
  • Kaiser Permanente-Vallejo, Vallejo, California, United States

    Contact: Study coordinator (Site Public Contact) · Kpoct@kp.org · 877-642-4691
    Contact: Principal Investigator (Andrea L. Harzstark)
  • Kaiser Permanente-Walnut Creek, Walnut Creek, California, United States

    Contact: Study coordinator (Site Public Contact) · Kpoct@kp.org · 877-642-4691
    Contact: Principal Investigator (Andrea L. Harzstark)
  • Kaiser Permanente-Woodland Hills, Woodland Hills, California, United States

    Contact: Study coordinator (Site Public Contact) · clinical.trials@kp.org · 800-398-3996
    Contact: Principal Investigator (Helen H. Moon)
  • UCHealth University of Colorado Hospital, Aurora, Colorado, United States

    Contact: Study coordinator (Site Public Contact) · 720-848-0650
    Contact: Principal Investigator (Elizabeth R. Kessler)
  • Kaiser Permanente-Franklin, Denver, Colorado, United States

    Contact: Study coordinator (Site Public Contact) · KPCOIHRClinicalResearch@kp.org · 303-817-9295
    Contact: Principal Investigator (Matthew J. Eadens)
  • Poudre Valley Hospital, Fort Collins, Colorado, United States

    Contact: Study coordinator (Site Public Contact) · 970-297-6150
    Contact: Principal Investigator (Elizabeth R. Kessler)
  • Cancer Care and Hematology-Fort Collins, Fort Collins, Colorado, United States

    Contact: Study coordinator (Site Public Contact) · protocols@AllianceNCTN.org · 773-702-9171
    Contact: Principal Investigator (Elizabeth R. Kessler)
  • UCHealth Greeley Hospital, Greeley, Colorado, United States

    Contact: Study coordinator (Site Public Contact) · protocols@AllianceNCTN.org · 773-702-9171
    Contact: Principal Investigator (Elizabeth R. Kessler)
  • UCHealth Highlands Ranch Hospital, Highlands Ranch, Colorado, United States

    Contact: Study coordinator (Site Public Contact) · 720-848-0650
    Contact: Principal Investigator (Elizabeth R. Kessler)
  • Kaiser Permanente-Rock Creek, Lafayette, Colorado, United States

    Contact: Study coordinator (Site Public Contact) · KPCOIHRClinicalResearch@kp.org · 303-817-9295
    Contact: Principal Investigator (Matthew J. Eadens)
  • Kaiser Permanente-Lone Tree, Lone Tree, Colorado, United States

    Contact: Study coordinator (Site Public Contact) · KPCOIHRClinicalResearch@kp.org · 303-817-9295
    Contact: Principal Investigator (Matthew J. Eadens)
  • UCHealth Lone Tree Health Center, Lone Tree, Colorado, United States

    Contact: Study coordinator (Site Public Contact) · protocols@AllianceNCTN.org · 773-702-9171
    Contact: Principal Investigator (Elizabeth R. Kessler)
  • Medical Center of the Rockies, Loveland, Colorado, United States

    Contact: Study coordinator (Site Public Contact) · 970-203-7083
    Contact: Principal Investigator (Elizabeth R. Kessler)
  • Hartford HealthCare - Avon, Avon, Connecticut, United States

    Contact: Study coordinator (Site Public Contact) · 860-972-4700
    Contact: Principal Investigator (Michael Sun)
  • Hartford HealthCare - Saint Vincent's Medical Center, Bridgeport, Connecticut, United States

    Contact: Study coordinator (Site Public Contact) · 860-972-4700
    Contact: Principal Investigator (Michael Sun)
  • Smilow Cancer Hospital-Derby Care Center, Derby, Connecticut, United States

    Contact: Study coordinator (Site Public Contact) · canceranswers@yale.edu · 203-785-5702
    Contact: Principal Investigator (Joseph W. Kim)
  • Hartford Healthcare - Fairfield, Fairfield, Connecticut, United States

    Contact: Study coordinator (Site Public Contact) · CancerResearchSupport@hhchealth.org · 860-972-4700
    Contact: Principal Investigator (Michael Sun)
  • Smilow Cancer Hospital Care Center-Fairfield, Fairfield, Connecticut, United States

    Contact: Study coordinator (Site Public Contact) · canceranswers@yale.edu · 203-785-5702
    Contact: Principal Investigator (Joseph W. Kim)
  • Smilow Cancer Hospital Care Center at Glastonbury, Glastonbury, Connecticut, United States

    Contact: Study coordinator (Site Public Contact) · canceranswers@yale.edu · 203-785-5702
    Contact: Principal Investigator (Joseph W. Kim)
  • Smilow Cancer Hospital Care Center at Greenwich, Greenwich, Connecticut, United States

    Contact: Study coordinator (Site Public Contact) · canceranswers@yale.edu · 203-785-5702
    Contact: Principal Investigator (Joseph W. Kim)
  • Smilow Cancer Hospital Care Center - Guilford, Guilford, Connecticut, United States

    Contact: Study coordinator (Site Public Contact) · canceranswers@yale.edu · 203-785-5702
    Contact: Principal Investigator (Joseph W. Kim)
  • Hartford Hospital, Hartford, Connecticut, United States

    Contact: Study coordinator (Site Public Contact) · 860-545-5363
    Contact: Principal Investigator (Michael Sun)
  • Smilow Cancer Hospital Care Center at Saint Francis, Hartford, Connecticut, United States

    Contact: Study coordinator (Site Public Contact) · canceranswers@yale.edu · 203-785-5702
    Contact: Principal Investigator (Joseph W. Kim)
  • Hartford HealthCare - Manchester, Manchester, Connecticut, United States

    Contact: Study coordinator (Site Public Contact) · 860-972-4700
    Contact: Principal Investigator (Michael Sun)
  • Midstate Medical Center, Meriden, Connecticut, United States

    Contact: Study coordinator (Site Public Contact) · 866-662-5678
    Contact: Principal Investigator (Michael Sun)
  • The Hospital of Central Connecticut, New Britain, Connecticut, United States

    Contact: Study coordinator (Site Public Contact) · 860-224-5660
    Contact: Principal Investigator (Michael Sun)
  • Yale University, New Haven, Connecticut, United States

    Contact: Study coordinator (Site Public Contact) · canceranswers@yale.edu · 203-785-5702
    Contact: Principal Investigator (Joseph W. Kim)
  • Yale-New Haven Hospital North Haven Medical Center, North Haven, Connecticut, United States

    Contact: Study coordinator (Site Public Contact) · canceranswers@yale.edu · 203-785-5702
    Contact: Principal Investigator (Joseph W. Kim)
  • Smilow Cancer Hospital Care Center at Long Ridge, Stamford, Connecticut, United States

    Contact: Study coordinator (Site Public Contact) · canceranswers@yale.edu · 203-785-5702
    Contact: Principal Investigator (Joseph W. Kim)
  • Smilow Cancer Hospital-Torrington Care Center, Torrington, Connecticut, United States

    Contact: Study coordinator (Site Public Contact) · canceranswers@yale.edu · 203-785-5702
    Contact: Principal Investigator (Joseph W. Kim)
  • Smilow Cancer Hospital Care Center-Trumbull, Trumbull, Connecticut, United States

    Contact: Study coordinator (Site Public Contact) · canceranswers@yale.edu · 203-785-5702
    Contact: Principal Investigator (Joseph W. Kim)
  • Smilow Cancer Hospital-Waterbury Care Center, Waterbury, Connecticut, United States

    Contact: Study coordinator (Site Public Contact) · canceranswers@yale.edu · 203-785-5702
    Contact: Principal Investigator (Joseph W. Kim)
  • Smilow Cancer Hospital Care Center - Waterford, Waterford, Connecticut, United States

    Contact: Study coordinator (Site Public Contact) · canceranswers@yale.edu · 203-785-5702
    Contact: Principal Investigator (Joseph W. Kim)
  • Helen F Graham Cancer Center, Newark, Delaware, United States

    Contact: Study coordinator (Site Public Contact) · lbarone@christianacare.org · 302-623-4450
    Contact: Principal Investigator (Gregory A. Masters)
  • Medical Oncology Hematology Consultants PA, Newark, Delaware, United States

    Contact: Study coordinator (Site Public Contact) · lbarone@christianacare.org · 302-623-4450
    Contact: Principal Investigator (Gregory A. Masters)
  • MedStar Georgetown University Hospital, Washington D.C., District of Columbia, United States

    Contact: Study coordinator (Site Public Contact) · 202-444-2223
    Contact: Principal Investigator (Nicholas I. Simon)
  • MedStar Washington Hospital Center, Washington D.C., District of Columbia, United States

    Contact: Study coordinator (Site Public Contact) · 202-877-8839
    Contact: Principal Investigator (Nicholas I. Simon)
  • Sibley Memorial Hospital, Washington D.C., District of Columbia, United States

    Contact: Study coordinator (Site Public Contact) · jquiver1@jhmi.edu · 202-243-2373
    Contact: Principal Investigator (Jean H. Hoffman-Censits)
  • George Washington University Medical Center, Washington D.C., District of Columbia, United States

    Contact: Study coordinator (Site Public Contact) · 202-741-2210
    Contact: Principal Investigator (Karan Jatwani)
  • Mount Sinai Comprehensive Cancer Center at Aventura, Aventura, Florida, United States

    Contact: Study coordinator (Site Public Contact) · yenrique@msmc.com · 305-674-2625
    Contact: Principal Investigator (Oleg Gligich)
  • UM Sylvester Comprehensive Cancer Center at Aventura, Aventura, Florida, United States

  • UM Sylvester Comprehensive Cancer Center at Coral Gables, Coral Gables, Florida, United States

    Contact: Study coordinator (Site Public Contact) · 305-243-2647
    Contact: Principal Investigator (Janaki N. Sharma)
  • UM Sylvester Comprehensive Cancer Center at Deerfield Beach, Deerfield Beach, Florida, United States

    Contact: Study coordinator (Site Public Contact) · 305-243-2647
    Contact: Principal Investigator (Janaki N. Sharma)
  • Malcom Randall Veterans Administration Medical Center, Gainesville, Florida, United States

    Contact: Study coordinator (Site Public Contact) · trials@cancer.ufl.edu · 352-273-8675
    Contact: Principal Investigator (Jess DeLaune)
  • UF Health Cancer Institute - Gainesville, Gainesville, Florida, United States

    Contact: Study coordinator (Site Public Contact) · cancer-center@ufl.edu · 352-273-8010
    Contact: Principal Investigator (Daniel V. Araujo)
  • Memorial Regional Hospital/Joe DiMaggio Children's Hospital, Hollywood, Florida, United States

    Contact: Study coordinator (Site Public Contact) · OHR@mhs.net · 954-265-1847
    Contact: Principal Investigator (Matthew P. Salzberg)
  • Mayo Clinic in Florida, Jacksonville, Florida, United States

    Contact: Study coordinator (Site Public Contact) · 855-776-0015
    Contact: Principal Investigator (Arnab Basu)
  • University of Miami Miller School of Medicine-Sylvester Cancer Center, Miami, Florida, United States

    Contact: Study coordinator (Site Public Contact) · 305-243-2647
    Contact: Principal Investigator (Janaki N. Sharma)
  • Miami Cancer Institute, Miami, Florida, United States

    Contact: Study coordinator (Site Public Contact) · 786-596-2000
    Contact: Principal Investigator (Rohan Garje)
  • UM Sylvester Comprehensive Cancer Center at Kendall, Miami, Florida, United States

    Contact: Study coordinator (Site Public Contact) · 305-243-2647
    Contact: Principal Investigator (Janaki N. Sharma)
  • Mount Sinai Medical Center, Miami Beach, Florida, United States

    Contact: Study coordinator (Site Public Contact) · Yvonne.Enriquez@msmc.com · 305-674-2625
    Contact: Principal Investigator (Oleg Gligich)
  • University of Miami Sylvester Comprehensive Cancer Center at Sole Mia, North Miami, Florida, United States

    Contact: Study coordinator (Site Public Contact) · kginnity@med.miami.edu
    Contact: Principal Investigator (Janaki N. Sharma)
  • AdventHealth Orlando, Orlando, Florida, United States

    Contact: Study coordinator (Site Public Contact) · FH.Cancer.Research@flhosp.org · 407-303-2090
    Contact: Principal Investigator (Guru P. Sonpavde)
  • Memorial Hospital West, Pembroke Pines, Florida, United States

    Contact: Study coordinator (Site Public Contact) · 954-265-4325
    Contact: Principal Investigator (Matthew P. Salzberg)
  • UM Sylvester Comprehensive Cancer Center at Plantation, Plantation, Florida, United States

    Contact: Study coordinator (Site Public Contact) · 305-243-2647
    Contact: Principal Investigator (Janaki N. Sharma)
  • Grady Health System, Atlanta, Georgia, United States

    Contact: Study coordinator (Site Public Contact) · 404-778-1868
    Contact: Principal Investigator (Jacqueline T. Brown)
  • Emory University Hospital Midtown, Atlanta, Georgia, United States

    Contact: Study coordinator (Site Public Contact) · 888-946-7447
    Contact: Principal Investigator (Jacqueline T. Brown)
  • Emory University Hospital/Winship Cancer Institute, Atlanta, Georgia, United States

    Contact: Study coordinator (Site Public Contact) · 404-778-1868
    Contact: Principal Investigator (Jacqueline T. Brown)
  • Emory Saint Joseph's Hospital, Atlanta, Georgia, United States

    Contact: Study coordinator (Site Public Contact) · 404-851-7115
    Contact: Principal Investigator (Jacqueline T. Brown)
  • Northside Hospital, Atlanta, Georgia, United States

    Contact: Study coordinator (Site Public Contact) · ClinicalTrials@northside.com · 404-303-3355
    Contact: Principal Investigator (Louis C. Garrot)
  • Northside Hospital - Duluth, Duluth, Georgia, United States

    Contact: Study coordinator (Site Public Contact) · Clinical.trials@northside.com · 404-303-3355
    Contact: Principal Investigator (Louis C. Garrot)
  • Emory Johns Creek Hospital, Johns Creek, Georgia, United States

    Contact: Study coordinator (Site Public Contact) · m.lisa.hwang@emory.edu · 404-778-5714
    Contact: Principal Investigator (Jacqueline T. Brown)
  • Northside Hospital - Gwinnett, Lawrenceville, Georgia, United States

    Contact: Study coordinator (Site Public Contact) · Clinical.trials@northside.com · 404-303-3355
    Contact: Principal Investigator (Louis C. Garrot)
  • Kaiser Permanente Moanalua Medical Center, Honolulu, Hawaii, United States

    Contact: Study coordinator (Site Public Contact) · shelley.a.clark@kp.org · 808-432-5195
    Contact: Principal Investigator (Andrea L. Harzstark)
  • Saint Alphonsus Cancer Care Center-Boise, Boise, Idaho, United States

    Contact: Study coordinator (Site Public Contact) · stephanie.couch@stjoeshealth.org · 734-712-3671
    Contact: Principal Investigator (Elie G. Dib)
  • Saint Alphonsus Cancer Care Center-Caldwell, Caldwell, Idaho, United States

    Contact: Study coordinator (Site Public Contact) · stephanie.couch@stjoeshealth.org · 734-712-3671
    Contact: Principal Investigator (Elie G. Dib)
  • Kootenai Health - Coeur d'Alene, Coeur d'Alene, Idaho, United States

    Contact: Study coordinator (Site Public Contact) · mccinfo@mtcancer.org · 406-969-6060
    Contact: Principal Investigator (John M. Schallenkamp)
  • Saint Alphonsus Cancer Care Center-Nampa, Nampa, Idaho, United States

    Contact: Study coordinator (Site Public Contact) · mccinfo@mtcancer.org · 406-969-6060
    Contact: Principal Investigator (Elie G. Dib)
  • Kootenai Clinic Cancer Services - Post Falls, Post Falls, Idaho, United States

    Contact: Study coordinator (Site Public Contact) · mccinfo@mtcancer.org · 406-969-6060
    Contact: Principal Investigator (John M. Schallenkamp)
  • Kootenai Clinic Cancer Services - Sandpoint, Sandpoint, Idaho, United States

    Contact: Study coordinator (Site Public Contact) · mccinfo@mtcancer.org · 406-969-6060
    Contact: Principal Investigator (John M. Schallenkamp)
  • Advocate Good Shepherd Hospital, Barrington, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · 847-842-4847
    Contact: Principal Investigator (Adam P. Siegel)
  • Illinois CancerCare-Bloomington, Bloomington, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · andersonj@illinoiscancercare.com · 309-243-3605
    Contact: Principal Investigator (Bryan A. Faller)
  • Illinois CancerCare-Canton, Canton, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · andersonj@illinoiscancercare.com · 309-243-3605
    Contact: Principal Investigator (Bryan A. Faller)
  • Illinois CancerCare-Carthage, Carthage, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · andersonj@illinoiscancercare.com · 309-243-3605
    Contact: Principal Investigator (Bryan A. Faller)
  • Northwestern University, Chicago, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · cancer@northwestern.edu · 312-695-1301
    Contact: Principal Investigator (David VanderWeele)
  • University of Illinois, Chicago, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · 312-355-3046
    Contact: Principal Investigator (Natalie Reizine)
  • Swedish Covenant Hospital, Chicago, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · 773-878-8200
    Contact: Principal Investigator (Nicklas R. Pfanzelter)
  • University of Chicago Comprehensive Cancer Center, Chicago, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · cancerclinicaltrials@bsd.uchicago.edu · 773-702-8222
    Contact: Principal Investigator (Randy F. Sweis)
  • Advocate Illinois Masonic Medical Center, Chicago, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · 773-296-5360
    Contact: Principal Investigator (Adam P. Siegel)
  • AMG Crystal Lake - Oncology, Crystal Lake, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · advocateresearch@advocate.com · 630-929-6129
    Contact: Principal Investigator (Adam P. Siegel)
  • Carle at The Riverfront, Danville, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · Research@Carle.com · 800-446-5532
    Contact: Principal Investigator (Priyank P. Patel)
  • Cancer Care Specialists of Illinois - Decatur, Decatur, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · morganthaler.jodi@mhsil.com · 217-876-4762
    Contact: Principal Investigator (Bryan A. Faller)
  • Decatur Memorial Hospital, Decatur, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · morganthaler.jodi@mhsil.com · 217-876-4762
    Contact: Principal Investigator (Bryan A. Faller)
  • Northwestern Medicine Cancer Center Kishwaukee, DeKalb, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · Donald.Smith3@nm.org · 630-352-5360
    Contact: Principal Investigator (David VanderWeele)
  • Illinois CancerCare-Dixon, Dixon, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · 815-285-7800
    Contact: Principal Investigator (Bryan A. Faller)
  • Advocate Good Samaritan Hospital, Downers Grove, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · Barbara.barhamand@advocatehealth.com · 630-275-1270
    Contact: Principal Investigator (Adam P. Siegel)
  • Carle Physician Group-Effingham, Effingham, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · Research@carle.com · 800-446-5532
    Contact: Principal Investigator (Priyank P. Patel)
  • Crossroads Cancer Center, Effingham, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · morganthaler.jodi@mhsil.com · 217-876-4762
    Contact: Principal Investigator (Bryan A. Faller)
  • Advocate Sherman Hospital, Elgin, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · 847-429-2907
    Contact: Principal Investigator (Adam P. Siegel)
  • Elmhurst Memorial Hospital, Elmhurst, Illinois, United States

  • Illinois CancerCare-Eureka, Eureka, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · andersonj@illinoiscancercare.com · 309-243-3605
    Contact: Principal Investigator (Bryan A. Faller)
  • NorthShore University HealthSystem-Evanston Hospital, Evanston, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · 847-570-2109
    Contact: Principal Investigator (Nicklas R. Pfanzelter)
  • Illinois CancerCare-Galesburg, Galesburg, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · andersonj@illinoiscancercare.com · 309-243-3605
    Contact: Principal Investigator (Bryan A. Faller)
  • Northwestern Medicine Cancer Center Delnor, Geneva, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · Donald.Smith3@nm.org · 630-352-5360
    Contact: Principal Investigator (David VanderWeele)
  • NorthShore University HealthSystem-Glenbrook Hospital, Glenview, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · 847-570-2109
    Contact: Principal Investigator (Nicklas R. Pfanzelter)
  • Northwestern Medicine Glenview Outpatient Center, Glenview, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · 312-695-1102
    Contact: Principal Investigator (David VanderWeele)
  • Northwestern Medicine Grayslake Outpatient Center, Grayslake, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · 312-695-1102
    Contact: Principal Investigator (David VanderWeele)
  • Ingalls Memorial Hospital, Harvey, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · clinicaltrials@ingalls.org · 708-915-4673
    Contact: Principal Investigator (James A. Wallace)
  • Advocate South Suburban Hospital, Hazel Crest, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · 708-799-9995
    Contact: Principal Investigator (Adam P. Siegel)
  • NorthShore University HealthSystem-Highland Park Hospital, Highland Park, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · 847-570-2109
    Contact: Principal Investigator (Nicklas R. Pfanzelter)
  • Illinois CancerCare-Kewanee Clinic, Kewanee, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · andersonj@illinoiscancercare.com · 309-243-3605
    Contact: Principal Investigator (Bryan A. Faller)
  • Northwestern Medicine Lake Forest Hospital, Lake Forest, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · cancertrials@northwestern.edu
    Contact: Principal Investigator (David VanderWeele)
  • AMG Libertyville - Oncology, Libertyville, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · advocateresearch@advocatehealth.com · 630-929-6129
    Contact: Principal Investigator (Adam P. Siegel)
  • Condell Memorial Hospital, Libertyville, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · advocateresearch@advocatehealth.com · 630-929-6129
    Contact: Principal Investigator (Adam P. Siegel)
  • Illinois CancerCare-Macomb, Macomb, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · andersonj@illinoiscancercare.com · 309-243-3605
    Contact: Principal Investigator (Bryan A. Faller)
  • Carle Physician Group-Mattoon/Charleston, Mattoon, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · Research@carle.com · 800-446-5532
    Contact: Principal Investigator (Priyank P. Patel)
  • Edward Hospital/Cancer Center, Naperville, Illinois, United States

  • UC Comprehensive Cancer Center at Silver Cross, New Lenox, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · cancerclinicaltrials@bsd.uchicago.edu · 773-702-8222
    Contact: Principal Investigator (Randy F. Sweis)
  • Cancer Care Center of O'Fallon, O'Fallon, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · morganthaler.jodi@mhsil.com · 217-876-4762
    Contact: Principal Investigator (Bryan A. Faller)
  • Northwestern Medicine Oak Brook, Oak Brook, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · nctnprogram_rhlccc@northwestern.edu
    Contact: Principal Investigator (David VanderWeele)
  • Advocate Christ Medical Center, Oak Lawn, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · 800-323-8622
    Contact: Principal Investigator (Adam P. Siegel)
  • Northwestern Medicine Orland Park, Orland Park, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · nctnprogram_rhlccc@northwestern.edu
    Contact: Principal Investigator (David VanderWeele)
  • University of Chicago Medicine-Orland Park, Orland Park, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · cancerclinicaltrials@bsd.uchicago.edu · 773-702-8222
    Contact: Principal Investigator (Randy F. Sweis)
  • Illinois CancerCare-Ottawa Clinic, Ottawa, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · andersonj@illinoiscancercare.com · 309-243-3605
    Contact: Principal Investigator (Bryan A. Faller)
  • Advocate Lutheran General Hospital, Park Ridge, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · 847-384-3621
    Contact: Principal Investigator (Adam P. Siegel)
  • Illinois CancerCare-Pekin, Pekin, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · andersonj@illinoiscancercare.com · 309-243-3605
    Contact: Principal Investigator (Bryan A. Faller)
  • Illinois CancerCare-Peoria, Peoria, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · andersonj@illinoiscancercare.com · 309-243-3605
    Contact: Principal Investigator (Bryan A. Faller)
  • Illinois CancerCare-Peru, Peru, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · andersonj@illinoiscancercare.com · 309-243-3605
    Contact: Principal Investigator (Bryan A. Faller)
  • Edward Hospital/Cancer Center?Plainfield, Plainfield, Illinois, United States

  • Illinois CancerCare-Princeton, Princeton, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · andersonj@illinoiscancercare.com · 309-243-3605
    Contact: Principal Investigator (Bryan A. Faller)
  • UW Health Carbone Cancer Center Rockford, Rockford, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · lkline@uwhealth.org · 779-696-9378
    Contact: Principal Investigator (Fahrettin Covut)
  • Memorial Hospital East, Shiloh, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · dschwab@wustl.edu · 314-747-9912
    Contact: Principal Investigator (Melissa A. Reimers)
  • Southern Illinois University School of Medicine, Springfield, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · 217-545-7929
    Contact: Principal Investigator (Bryan A. Faller)
  • Springfield Clinic, Springfield, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · 800-444-7541
    Contact: Principal Investigator (Bryan A. Faller)
  • Springfield Memorial Hospital, Springfield, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · pallante.beth@mhsil.com · 217-528-7541
    Contact: Principal Investigator (Bryan A. Faller)
  • Carle Cancer Center, Urbana, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · Research@carle.com · 800-446-5532
    Contact: Principal Investigator (Priyank P. Patel)
  • Northwestern Medicine Cancer Center Warrenville, Warrenville, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · Donald.Smith3@nm.org · 630-352-5360
    Contact: Principal Investigator (David VanderWeele)
  • Illinois CancerCare - Washington, Washington, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · andersonj@illinoiscancercare.com · 309-243-3605
    Contact: Principal Investigator (Bryan A. Faller)
  • UChicago Medicine Northwest Indiana, Crown Point, Indiana, United States

    Contact: Study coordinator (Site Public Contact) · cancerclinicaltrials@bsd.uchicago.edu · 855-702-8222
    Contact: Principal Investigator (Randy F. Sweis)
  • Indiana University/Melvin and Bren Simon Cancer Center, Indianapolis, Indiana, United States

    Contact: Study coordinator (Site Public Contact) · iutrials@iu.edu · 317-278-5632
    Contact: Principal Investigator (Tareq Salous)
  • Mary Greeley Medical Center, Ames, Iowa, United States

    Contact: Study coordinator (Site Public Contact) · 515-956-4132
    Contact: Principal Investigator (Joseph J. Merchant)
  • McFarland Clinic - Ames, Ames, Iowa, United States

    Contact: Study coordinator (Site Public Contact) · ksoder@mcfarlandclinic.com · 515-239-4734
    Contact: Principal Investigator (Joseph J. Merchant)
  • UI Health Care Mission Cancer and Blood - Ankeny Clinic, Ankeny, Iowa, United States

    Contact: Study coordinator (Site Public Contact) · 515-241-3305
    Contact: Principal Investigator (Richard L. Deming)
  • McFarland Clinic - Boone, Boone, Iowa, United States

  • UI Health Care Mission Cancer and Blood - West Des Moines Clinic, Clive, Iowa, United States

    Contact: Study coordinator (Site Public Contact) · 515-241-3305
    Contact: Principal Investigator (Seema Harichand-Herdt)
  • Iowa Methodist Medical Center, Des Moines, Iowa, United States

    Contact: Study coordinator (Site Public Contact) · 515-241-6727
    Contact: Principal Investigator (Seema Harichand-Herdt)
  • UI Health Care Mission Cancer and Blood - Des Moines Clinic, Des Moines, Iowa, United States

    Contact: Study coordinator (Site Public Contact) · 515-241-3305
    Contact: Principal Investigator (Seema Harichand-Herdt)
  • Mercy Medical Center - Des Moines, Des Moines, Iowa, United States

    Contact: Study coordinator (Site Public Contact) · 515-241-3305
    Contact: Principal Investigator (Richard L. Deming)
  • UI Health Care Mission Cancer and Blood - Laurel Clinic, Des Moines, Iowa, United States

    Contact: Study coordinator (Site Public Contact) · 515-241-3305
    Contact: Principal Investigator (Seema Harichand-Herdt)
  • McFarland Clinic - Trinity Cancer Center, Fort Dodge, Iowa, United States

    Contact: Study coordinator (Site Public Contact) · 515-956-4132
    Contact: Principal Investigator (Joseph J. Merchant)
  • University of Iowa/Holden Comprehensive Cancer Center, Iowa City, Iowa, United States

    Contact: Study coordinator (Site Public Contact) · 800-237-1225
    Contact: Principal Investigator (Fernando Maciel Barbosa)
  • McFarland Clinic - Jefferson, Jefferson, Iowa, United States

  • McFarland Clinic - Marshalltown, Marshalltown, Iowa, United States

    Contact: Study coordinator (Site Public Contact) · 515-956-4132
    Contact: Principal Investigator (Joseph J. Merchant)
  • UI Health Care Mission Cancer and Blood - Waukee Clinic, Waukee, Iowa, United States

    Contact: Study coordinator (Site Public Contact) · 515-241-3305
    Contact: Principal Investigator (Seema Harichand-Herdt)
  • HaysMed, Hays, Kansas, United States

    Contact: Study coordinator (Site Public Contact) · 785-623-5774
    Contact: Principal Investigator (Saqib Abbasi)
  • University of Kansas Cancer Center, Kansas City, Kansas, United States

    Contact: Study coordinator (Site Public Contact) · KUCC_Navigation@kumc.edu · 913-588-3671
    Contact: Principal Investigator (Saqib Abbasi)
  • Lawrence Memorial Hospital, Lawrence, Kansas, United States

    Contact: Study coordinator (Site Public Contact) · Stephanie.Norris@LMH.ORG · 785-505-2800
    Contact: Principal Investigator (Saqib Abbasi)
  • The University of Kansas Cancer Center - Olathe, Olathe, Kansas, United States

    Contact: Study coordinator (Site Public Contact) · OlatheCCResearch@kumc.edu · 913-588-1569
    Contact: Principal Investigator (Saqib Abbasi)
  • University of Kansas Cancer Center-Overland Park, Overland Park, Kansas, United States

    Contact: Study coordinator (Site Public Contact) · KUCC_Navigation@kumc.edu · 913-588-3671
    Contact: Principal Investigator (Saqib Abbasi)
  • Salina Regional Health Center, Salina, Kansas, United States

    Contact: Study coordinator (Site Public Contact) · mleepers@srhc.com · 785-452-7038
    Contact: Principal Investigator (Saqib Abbasi)
  • University of Kansas Health System Saint Francis Campus, Topeka, Kansas, United States

    Contact: Study coordinator (Site Public Contact) · 785-295-8000
    Contact: Principal Investigator (Saqib Abbasi)
  • University of Kansas Hospital-Westwood Cancer Center, Westwood, Kansas, United States

    Contact: Study coordinator (Site Public Contact) · KUCC_Navigation@kumc.edu · 913-588-3671
    Contact: Principal Investigator (Saqib Abbasi)
  • University of Kentucky/Markey Cancer Center, Lexington, Kentucky, United States

    Contact: Study coordinator (Site Public Contact) · 859-257-3379
    Contact: Principal Investigator (Patrick J. Hensley)
  • The James Graham Brown Cancer Center at University of Louisville, Louisville, Kentucky, United States

    Contact: Study coordinator (Site Public Contact) · 502-562-3429
    Contact: Principal Investigator (Rohit Kumar)
  • Baptist Health Louisville, Louisville, Kentucky, United States

  • UofL Health Medical Center Northeast, Louisville, Kentucky, United States

    Contact: Study coordinator (Site Public Contact) · ctoinfo@louisville.edu · 502-852-2755
    Contact: Principal Investigator (Rohit Kumar)
  • Louisiana Hematology Oncology Associates LLC, Baton Rouge, Louisiana, United States

    Contact: Study coordinator (Site Public Contact) · clinicalresearch@marybird.com · 225-215-1353
    Contact: Principal Investigator (Scott E. Delacroix)
  • Mary Bird Perkins Cancer Center - Metairie, Metairie, Louisiana, United States

    Contact: Study coordinator (Site Public Contact) · 504-584-6990
    Contact: Principal Investigator (Scott E. Delacroix)
  • Ochsner Medical Center Jefferson, New Orleans, Louisiana, United States

    Contact: Study coordinator (Site Public Contact) · Elisemarie.curry@ochsner.org · 504-842-8084
    Contact: Principal Investigator (Brian T. Halbert)
  • Lafayette Family Cancer Center-EMMC, Brewer, Maine, United States

    Contact: Study coordinator (Site Public Contact) · 800-987-3005
    Contact: Principal Investigator (Sarah J. Sinclair)
  • University of Maryland/Greenebaum Cancer Center, Baltimore, Maryland, United States

    Contact: Study coordinator (Site Public Contact) · 800-888-8823
    Contact: Principal Investigator (Heather D. Mannuel)
  • Johns Hopkins University/Sidney Kimmel Cancer Center, Baltimore, Maryland, United States

    Contact: Study coordinator (Site Public Contact) · jhcccro@jhmi.edu · 410-955-8804
    Contact: Principal Investigator (Jean H. Hoffman-Censits)
  • UPMC Western Maryland, Cumberland, Maryland, United States

    Contact: Study coordinator (Site Public Contact) · 240-964-1400
    Contact: Principal Investigator (Leonard J. Appleman)
  • FMH James M Stockman Cancer Institute, Frederick, Maryland, United States

    Contact: Study coordinator (Site Public Contact) · 301-668-7043
    Contact: Principal Investigator (Saro Sarkisian)
  • Beverly Hospital, Beverly, Massachusetts, United States

    Contact: Study coordinator (Site Public Contact) · 978-922-3000
    Contact: Principal Investigator (Brett Dumas)
  • Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States

    Contact: Study coordinator (Site Public Contact) · 617-667-9925
    Contact: Principal Investigator (David Einstein)
  • Dana-Farber Cancer Institute, Boston, Massachusetts, United States

    Contact: Study coordinator (Site Public Contact) · 877-442-3324
    Contact: Principal Investigator (Stephanie A. Berg)
  • Dana-Farber Cancer Institute at Boston Medical Center - Brighton, Brighton, Massachusetts, United States

    Contact: Study coordinator (Site Public Contact) · 617-789-2903
    Contact: Principal Investigator (Olga Kozyreva)
  • Lahey Clinic, Burlington, Massachusetts, United States

    Contact: Study coordinator (Site Public Contact) · lhmc-cancer-clinical-trials@lahey.org · 781-744-3421
    Contact: Principal Investigator (Brett Dumas)
  • Dana-Farber Cancer Institute at Foxborough, Foxborough, Massachusetts, United States

    Contact: Study coordinator (Site Public Contact) · 877-338-7425
    Contact: Principal Investigator (Daniel Roberts)
  • Addison Gilbert Hospital, Gloucester, Massachusetts, United States

    Contact: Study coordinator (Site Public Contact) · 978-283-4000
    Contact: Principal Investigator (Brett Dumas)
  • Dana-Farber/Brigham and Women's Cancer Center at Milford Regional, Milford, Massachusetts, United States

    Contact: Study coordinator (Site Public Contact) · 877-332-4294
    Contact: Principal Investigator (Daniel E. Fein)
  • Lahey Clinic Peabody, Peabody, Massachusetts, United States

    Contact: Study coordinator (Site Public Contact) · lhmc-cancer-clinical-trials@lahey.org · 781-744-3421
    Contact: Principal Investigator (Brett Dumas)
  • Dana-Farber/Brigham and Women's Cancer Center at South Shore, South Weymouth, Massachusetts, United States

    Contact: Study coordinator (Site Public Contact) · 781-624-5000
    Contact: Principal Investigator (Shail Maingi)
  • Beth Israel Deaconess Medical Center/Winchester Center for Cancer Care, Winchester, Massachusetts, United States

  • Trinity Health Saint Joseph Mercy Hospital Ann Arbor, Ann Arbor, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · MCRCwebsitecontactform@stjoeshealth.org · 734-712-7251
    Contact: Principal Investigator (Elie G. Dib)
  • University of Michigan Rogel Cancer Center, Ann Arbor, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · CancerAnswerLine@med.umich.edu · 800-865-1125
    Contact: Principal Investigator (Irene Tsung)
  • Bronson Battle Creek, Battle Creek, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · crcwm-regulatory@crcwm.org · 616-391-1230
    Contact: Principal Investigator (Kathleen Y. Butler)
  • McLaren Cancer Institute-Bay City, Bay City, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · ctoadmin@karmanos.org · 313-576-9790
    Contact: Principal Investigator (Yusra F. Shao)
  • Trinity Health IHA Medical Group Hematology Oncology - Brighton, Brighton, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · MCRCwebsitecontactform@stjoeshealth.org · 734-712-7251
    Contact: Principal Investigator (Elie G. Dib)
  • University of Michigan - Brighton Center for Specialty Care, Brighton, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · 800-865-1125
    Contact: Principal Investigator (Irene Tsung)
  • Henry Ford Cancer Institute-Downriver, Brownstown, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · CTOResearch@hfhs.org · 313-916-3721
    Contact: Principal Investigator (Clara Hwang)
  • Trinity Health IHA Medical Group Hematology Oncology - Canton, Canton, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · MCRCwebsitecontactform@stjoeshealth.org · 734-712-7251
    Contact: Principal Investigator (Elie G. Dib)
  • Trinity Health IHA Medical Group Hematology Oncology - Chelsea Hospital, Chelsea, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · MCRCwebsitecontactform@stjoeshealth.org · 734-712-7251
    Contact: Principal Investigator (Elie G. Dib)
  • Henry Ford Macomb Hospital-Clinton Township, Clinton Township, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · CTOResearch@hfhs.org · 313-916-3721
    Contact: Principal Investigator (Clara Hwang)
  • Henry Ford Medical Center-Fairlane, Dearborn, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · CTOResearch@hfhs.org · 313-916-3721
    Contact: Principal Investigator (Clara Hwang)
  • Wayne State University/Karmanos Cancer Institute, Detroit, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · ctoadmin@karmanos.org · 800-527-6266
    Contact: Principal Investigator (Yusra F. Shao)
  • Henry Ford Hospital, Detroit, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · CTOResearch@hfhs.org · 313-916-3721
    Contact: Principal Investigator (Clara Hwang)
  • OSF Saint Francis Hospital and Medical Group, Escanaba, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · WI_research_admin@hshs.org · 920-433-8889
    Contact: Principal Investigator (Anthony J. Jaslowski)
  • Weisberg Cancer Treatment Center, Farmington Hills, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · ctoadmin@karmanos.org · 313-576-9790
    Contact: Principal Investigator (Yusra F. Shao)
  • Cancer Hematology Centers - Flint, Flint, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · wstrong@ghci.org · 810-762-8038
    Contact: Principal Investigator (Elie G. Dib)
  • Genesee Hematology Oncology PC, Flint, Michigan, United States

  • Genesys Hurley Cancer Institute, Flint, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · wstrong@ghci.org · 810-762-8038
    Contact: Principal Investigator (Elie G. Dib)
  • Hurley Medical Center, Flint, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · wstrong@ghci.org · 810-762-8038
    Contact: Principal Investigator (Elie G. Dib)
  • Corewell Health Grand Rapids Hospitals - Butterworth Hospital, Grand Rapids, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · crcwm-regulatory@crcwm.org · 616-391-1230
    Contact: Principal Investigator (Kathleen Y. Butler)
  • Trinity Health Grand Rapids Hospital, Grand Rapids, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · crcwm-regulatory@crcwm.org · 616-391-1230
    Contact: Principal Investigator (Kathleen Y. Butler)
  • Allegiance Health, Jackson, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · CTOResearch@hfhs.org · 313-916-3721
    Contact: Principal Investigator (Clara Hwang)
  • Bronson Methodist Hospital, Kalamazoo, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · crcwm-regulatory@crcwm.org · 616-391-1230
    Contact: Principal Investigator (Kathleen Y. Butler)
  • West Michigan Cancer Center, Kalamazoo, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · crcwm-regulatory@crcwm.org · 616-391-1230
    Contact: Principal Investigator (Kathleen Y. Butler)
  • Karmanos Cancer Institute at McLaren Greater Lansing, Lansing, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · ctoadmin@karmanos.org · 313-576-9790
    Contact: Principal Investigator (Yusra F. Shao)
  • University of Michigan Health - Sparrow Lansing, Lansing, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · harsha.trivedi@umhsparrow.org · 517-364-3712
    Contact: Principal Investigator (Elie G. Dib)
  • Trinity Health Saint Mary Mercy Livonia Hospital, Livonia, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · MCRCwebsitecontactform@stjoeshealth.org · 734-712-7251
    Contact: Principal Investigator (Elie G. Dib)
  • Trinity Health Muskegon Hospital, Muskegon, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · crcwm-regulatory@crcwm.org · 616-391-1230
    Contact: Principal Investigator (Kathleen Y. Butler)
  • Corewell Health Lakeland Hospitals - Niles Hospital, Niles, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · 616-391-1230
    Contact: Principal Investigator (Kathleen Y. Butler)
  • Cancer and Hematology Centers of Western Michigan - Norton Shores, Norton Shores, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · connie.szczepanek@crcwm.org · 616-391-1230
    Contact: Principal Investigator (Kathleen Y. Butler)
  • Henry Ford Medical Center-Columbus, Novi, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · CTOResearch@hfhs.org · 313-916-3721
    Contact: Principal Investigator (Clara Hwang)
  • McLaren Cancer Institute-Northern Michigan, Petoskey, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · ctoadmin@karmanos.org · 313-576-9790
    Contact: Principal Investigator (Yusra F. Shao)
  • Trinity Health Saint Joseph Mercy Oakland Hospital, Pontiac, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · MCRCwebsitecontactform@stjoeshealth.org · 734-712-7251
    Contact: Principal Investigator (Elie G. Dib)
  • Corewell Health Reed City Hospital, Reed City, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · crcwm-regulatory@crcwm.org · 616-391-1230
    Contact: Principal Investigator (Kathleen Y. Butler)
  • MyMichigan Medical Center Saginaw, Saginaw, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · MCRCwebsitecontactform@stjoeshealth.org · 734-712-7251
    Contact: Principal Investigator (Elie G. Dib)
  • Oncology Hematology Associates of Saginaw Valley PC, Saginaw, Michigan, United States

  • Corewell Health Lakeland Hospitals - Marie Yeager Cancer Center, Saint Joseph, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · crcwm-regulatory@crcwm.org · 616-391-1230
    Contact: Principal Investigator (Kathleen Y. Butler)
  • Corewell Health Lakeland Hospitals - Saint Joseph Hospital, Saint Joseph, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · crcwm-regulatory@crcwm.org · 616-391-1230
    Contact: Principal Investigator (Kathleen Y. Butler)
  • MyMichigan Medical Center Tawas, Tawas City, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · MCRCwebsitecontactform@stjoeshealth.org · 734-712-7251
    Contact: Principal Investigator (Elie G. Dib)
  • Munson Medical Center, Traverse City, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · crcwm-regulatory@crcwm.org · 616-391-1230
    Contact: Principal Investigator (Kathleen Y. Butler)
  • Henry Ford West Bloomfield Hospital, West Bloomfield, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · CTOResearch@hfhs.org · 313-916-3721
    Contact: Principal Investigator (Clara Hwang)
  • Saint Mary's Oncology/Hematology Associates of West Branch, West Branch, Michigan, United States

  • Henry Ford Wyandotte Hospital, Wyandotte, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · nhay@hfhs.org
    Contact: Principal Investigator (Clara Hwang)
  • University of Michigan Health - West, Wyoming, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · crcwm-regulatory@crcwm.org · 616-391-1230
    Contact: Principal Investigator (Kathleen Y. Butler)
  • Trinity Health IHA Medical Group Hematology Oncology Ann Arbor Campus, Ypsilanti, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · MCRCwebsitecontactform@stjoeshealth.org · 734-712-7251
    Contact: Principal Investigator (Elie G. Dib)
  • Sanford Joe Lueken Cancer Center, Bemidji, Minnesota, United States

    Contact: Study coordinator (Site Public Contact) · OncologyClinicalTrialsFargo@sanfordhealth.org · 218-333-5000
    Contact: Principal Investigator (Daniel Almquist)
  • Mercy Hospital, Coon Rapids, Minnesota, United States

    Contact: Study coordinator (Site Public Contact) · mmcorc@healthpartners.com · 952-993-1517
    Contact: Principal Investigator (Daniel M. Anderson)
  • Fairview Southdale Hospital, Edina, Minnesota, United States

    Contact: Study coordinator (Site Public Contact) · mmcorc@healthpartners.com · 952-993-1517
    Contact: Principal Investigator (Daniel M. Anderson)
  • Abbott-Northwestern Hospital, Minneapolis, Minnesota, United States

    Contact: Study coordinator (Site Public Contact) · mmcorc@healthpartners.com · 952-993-1517
    Contact: Principal Investigator (Daniel M. Anderson)
  • Hennepin County Medical Center, Minneapolis, Minnesota, United States

    Contact: Study coordinator (Site Public Contact) · mmcorc@healthpartners.com · 952-993-1517
    Contact: Principal Investigator (Daniel M. Anderson)
  • Coborn Cancer Center at Saint Cloud Hospital, Saint Cloud, Minnesota, United States

    Contact: Study coordinator (Site Public Contact) · coborncancercenter@centracare.com · 877-229-4907
    Contact: Principal Investigator (Donald J. Jurgens)
  • Park Nicollet Clinic - Saint Louis Park, Saint Louis Park, Minnesota, United States

    Contact: Study coordinator (Site Public Contact) · mmcorc@healthpartners.com · 952-993-1517
    Contact: Principal Investigator (Daniel M. Anderson)
  • Regions Hospital, Saint Paul, Minnesota, United States

    Contact: Study coordinator (Site Public Contact) · mmcorc@healthpartners.com · 952-993-1517
    Contact: Principal Investigator (Daniel M. Anderson)
  • United Hospital, Saint Paul, Minnesota, United States

    Contact: Study coordinator (Site Public Contact) · mmcorc@healthpartners.com · 952-993-1517
    Contact: Principal Investigator (Daniel M. Anderson)
  • University of Mississippi Medical Center, Jackson, Mississippi, United States

    Contact: Study coordinator (Site Public Contact) · 601-815-6700
    Contact: Principal Investigator (John C. Henegan)
  • Saint Francis Medical Center, Cape Girardeau, Missouri, United States

    Contact: Study coordinator (Site Public Contact) · sfmc@sfmc.net · 573-334-2230
    Contact: Principal Investigator (Bryan A. Faller)
  • Siteman Cancer Center at Saint Peters Hospital, City of Saint Peters, Missouri, United States

    Contact: Study coordinator (Site Public Contact) · info@siteman.wustl.edu · 800-600-3606
    Contact: Principal Investigator (Melissa A. Reimers)
  • MU Health - University Hospital/Ellis Fischel Cancer Center, Columbia, Missouri, United States

    Contact: Study coordinator (Site Public Contact) · 573-882-7440
    Contact: Principal Investigator (Mark R. Wakefield)
  • Siteman Cancer Center at West County Hospital, Creve Coeur, Missouri, United States

    Contact: Study coordinator (Site Public Contact) · info@siteman.wustl.edu · 800-600-3606
    Contact: Principal Investigator (Melissa A. Reimers)
  • Parkland Health Center - Farmington, Farmington, Missouri, United States

    Contact: Study coordinator (Site Public Contact) · 314-996-5569
    Contact: Principal Investigator (Bryan A. Faller)
  • MU Health Care Goldschmidt Cancer Center, Jefferson City, Missouri, United States

  • University Health Truman Medical Center, Kansas City, Missouri, United States

    Contact: Study coordinator (Site Public Contact) · 816-404-4375
    Contact: Principal Investigator (Saqib Abbasi)
  • University of Kansas Cancer Center - Briarcliff, Kansas City, Missouri, United States

    Contact: Study coordinator (Site Public Contact) · 913-588-3671
    Contact: Principal Investigator (Saqib Abbasi)
  • Kansas City Veterans Affairs Medical Center, Kansas City, Missouri, United States

  • University of Kansas Cancer Center - North, Kansas City, Missouri, United States

    Contact: Study coordinator (Site Public Contact) · KUCC_Navigation@kumc.edu · 913-588-3671
    Contact: Principal Investigator (Saqib Abbasi)
  • University of Kansas Cancer Center - Lee's Summit, Lee's Summit, Missouri, United States

    Contact: Study coordinator (Site Public Contact) · KUCC_Navigation@kumc.edu · 913-588-3671
    Contact: Principal Investigator (Saqib Abbasi)
  • University of Kansas Cancer Center at North Kansas City Hospital, North Kansas City, Missouri, United States

  • Sainte Genevieve County Memorial Hospital, Sainte Genevieve, Missouri, United States

    Contact: Study coordinator (Site Public Contact) · 314-996-5569
    Contact: Principal Investigator (Bryan A. Faller)
  • Mercy Hospital Springfield, Springfield, Missouri, United States

    Contact: Study coordinator (Site Public Contact) · 417-269-4520
    Contact: Principal Investigator (Jay W. Carlson)
  • Washington University School of Medicine, St Louis, Missouri, United States

    Contact: Study coordinator (Site Public Contact) · info@siteman.wustl.edu · 800-600-3606
    Contact: Principal Investigator (Melissa A. Reimers)
  • Veteran's Affairs Medical Center - Saint Louis, St Louis, Missouri, United States

    Contact: Study coordinator (Site Public Contact) · protocols@AllianceNCTN.org · 773-702-9171
    Contact: Principal Investigator (Eric M. Knoche)
  • Mercy Hospital South, St Louis, Missouri, United States

    Contact: Study coordinator (Site Public Contact) · Danielle.Werle@mercy.net · 314-525-6042
    Contact: Principal Investigator (Jay W. Carlson)
  • Siteman Cancer Center-South County, St Louis, Missouri, United States

    Contact: Study coordinator (Site Public Contact) · info@siteman.wustl.edu · 800-600-3606
    Contact: Principal Investigator (Melissa A. Reimers)
  • Missouri Baptist Medical Center, St Louis, Missouri, United States

    Contact: Study coordinator (Site Public Contact) · 314-996-5569
    Contact: Principal Investigator (Bryan A. Faller)
  • Siteman Cancer Center at Christian Hospital, St Louis, Missouri, United States

    Contact: Study coordinator (Site Public Contact) · info@siteman.wustl.edu · 800-600-3606
    Contact: Principal Investigator (Melissa A. Reimers)
  • Mercy Hospital Saint Louis, St Louis, Missouri, United States

    Contact: Study coordinator (Site Public Contact) · 314-251-7066
    Contact: Principal Investigator (Jay W. Carlson)
  • Missouri Baptist Sullivan Hospital, Sullivan, Missouri, United States

    Contact: Study coordinator (Site Public Contact) · 314-996-5569
    Contact: Principal Investigator (Bryan A. Faller)
  • BJC Outpatient Center at Sunset Hills, Sunset Hills, Missouri, United States

    Contact: Study coordinator (Site Public Contact) · 314-996-5569
    Contact: Principal Investigator (Bryan A. Faller)
  • Community Hospital of Anaconda, Anaconda, Montana, United States

    Contact: Study coordinator (Site Public Contact) · mccinfo@mtcancer.org · 406-969-6060
    Contact: Principal Investigator (John M. Schallenkamp)
  • Billings Clinic Cancer Center, Billings, Montana, United States

    Contact: Study coordinator (Site Public Contact) · research@billingsclinic.org · 800-996-2663
    Contact: Principal Investigator (John M. Schallenkamp)
  • Bozeman Health Deaconess Hospital, Bozeman, Montana, United States

    Contact: Study coordinator (Site Public Contact) · mccinfo@mtcancer.org · 406-969-6060
    Contact: Principal Investigator (John M. Schallenkamp)
  • Benefis Sletten Cancer Institute, Great Falls, Montana, United States

    Contact: Study coordinator (Site Public Contact) · mccinfo@mtcancer.org · 406-969-6060
    Contact: Principal Investigator (John M. Schallenkamp)
  • Logan Health Medical Center, Kalispell, Montana, United States

    Contact: Study coordinator (Site Public Contact) · mccinfo@mtcancer.org · 406-969-6060
    Contact: Principal Investigator (John M. Schallenkamp)
  • Community Medical Center, Missoula, Montana, United States

    Contact: Study coordinator (Site Public Contact) · mccinfo@mtcancer.org · 406-969-6060
    Contact: Principal Investigator (John M. Schallenkamp)
  • Nebraska Medicine-Bellevue, Bellevue, Nebraska, United States

    Contact: Study coordinator (Site Public Contact) · unmcrsa@unmc.edu · 402-559-6941
    Contact: Principal Investigator (Harshraj Leuva)
  • Nebraska Medicine-Village Pointe, Omaha, Nebraska, United States

    Contact: Study coordinator (Site Public Contact) · 402-559-5600
    Contact: Principal Investigator (Harshraj Leuva)
  • University of Nebraska Medical Center, Omaha, Nebraska, United States

    Contact: Study coordinator (Site Public Contact) · unmcrsa@unmc.edu · 402-559-6941
    Contact: Principal Investigator (Harshraj Leuva)
  • OptumCare Cancer Care at Charleston, Las Vegas, Nevada, United States

    Contact: Study coordinator (Site Public Contact) · research@sncrf.org · 702-384-0013
    Contact: Principal Investigator (John A. Ellerton)
  • OptumCare Cancer Care at Fort Apache, Las Vegas, Nevada, United States

    Contact: Study coordinator (Site Public Contact) · research@sncrf.org · 702-384-0013
    Contact: Principal Investigator (John A. Ellerton)
  • New Hampshire Oncology Hematology PA-Concord, Concord, New Hampshire, United States

  • Solinsky Center for Cancer Care, Manchester, New Hampshire, United States

  • Memorial Sloan Kettering Basking Ridge, Basking Ridge, New Jersey, United States

    Contact: Study coordinator (Site Public Contact) · 212-639-7592
    Contact: Principal Investigator (David H. Aggen)
  • Jefferson Cherry Hill Hospital, Cherry Hill, New Jersey, United States

    Contact: Study coordinator (Site Public Contact) · ONCTrialNow@jefferson.edu · 215-600-9151
    Contact: Principal Investigator (Patrick Mille)
  • Hackensack University Medical Center, Hackensack, New Jersey, United States

    Contact: Study coordinator (Site Public Contact) · 551-996-2897
    Contact: Principal Investigator (Robert S. Alter)
  • Jersey City Medical Center, Jersey City, New Jersey, United States

    Contact: Study coordinator (Site Public Contact) · ctsucontact@westat.com · 888-823-5923
    Contact: Principal Investigator (Biren Saraiya)
  • Monmouth Medical Center Southern Campus, Lakewood, New Jersey, United States

    Contact: Study coordinator (Site Public Contact) · mary.danish@rwjbh.org · 732-923-6564
    Contact: Principal Investigator (Biren Saraiya)
  • Saint Barnabas Medical Center, Livingston, New Jersey, United States

    Contact: Study coordinator (Site Public Contact) · joanne.loeb@rwjbh.org · 973-322-2934
    Contact: Principal Investigator (Biren Saraiya)
  • Monmouth Medical Center, Long Branch, New Jersey, United States

    Contact: Study coordinator (Site Public Contact) · mary.danish@rwjbh.org · 732-923-6564
    Contact: Principal Investigator (Biren Saraiya)
  • Southern Ocean County Medical Center, Manahawkin, New Jersey, United States

    Contact: Study coordinator (Site Public Contact) · 609-978-3429
    Contact: Principal Investigator (Evan C. Naylor)
  • Memorial Sloan Kettering Monmouth, Middletown, New Jersey, United States

    Contact: Study coordinator (Site Public Contact) · 212-639-7592
    Contact: Principal Investigator (David H. Aggen)
  • Memorial Sloan Kettering Bergen, Montvale, New Jersey, United States

    Contact: Study coordinator (Site Public Contact) · 212-639-7592
    Contact: Principal Investigator (David H. Aggen)
  • Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey, United States

    Contact: Study coordinator (Site Public Contact) · 732-235-7356
    Contact: Principal Investigator (Biren Saraiya)
  • Sidney Kimmel Cancer Center Washington Township, Sewell, New Jersey, United States

    Contact: Study coordinator (Site Public Contact) · ONCTrialNow@jefferson.edu · 215-600-9151
    Contact: Principal Investigator (Patrick Mille)
  • Robert Wood Johnson University Hospital Somerset, Somerville, New Jersey, United States

    Contact: Study coordinator (Site Public Contact) · Siby.Varughese@rwjbh.org · 908-685-2481
    Contact: Principal Investigator (Biren Saraiya)
  • Community Medical Center, Toms River, New Jersey, United States

    Contact: Study coordinator (Site Public Contact) · Lennette.Gonzales@rwjbh.org · 732-557-8294
    Contact: Principal Investigator (Biren Saraiya)
  • University of New Mexico Cancer Center, Albuquerque, New Mexico, United States

  • Presbyterian Kaseman Hospital, Albuquerque, New Mexico, United States

    Contact: Study coordinator (Site Public Contact) · WBurman@phs.org · 505-559-6113
    Contact: Principal Investigator (Amy C. Tarnower)
  • Presbyterian Rust Medical Center/Jorgensen Cancer Center, Rio Rancho, New Mexico, United States

    Contact: Study coordinator (Site Public Contact) · WBurman@phs.org · 505-559-6113
    Contact: Principal Investigator (Amy C. Tarnower)
  • Maimonides Medical Center, Brooklyn, New York, United States

    Contact: Study coordinator (Site Public Contact) · 718-765-2500
    Contact: Principal Investigator (Abhigna Kodali)
  • Roswell Park Cancer Institute, Buffalo, New York, United States

  • Memorial Sloan Kettering Commack, Commack, New York, United States

    Contact: Study coordinator (Site Public Contact) · 212-639-7592
    Contact: Principal Investigator (David H. Aggen)
  • The New York Hospital Medical Center of Queens, Flushing, New York, United States

    Contact: Study coordinator (Site Public Contact) · ctsucontact@westat.com · 888-823-5923
    Contact: Principal Investigator (Leen Khoury)
  • Glens Falls Hospital, Glens Falls, New York, United States

    Contact: Study coordinator (Site Public Contact) · 518-926-6700
    Contact: Principal Investigator (Steven Ades)
  • Memorial Sloan Kettering Westchester, Harrison, New York, United States

    Contact: Study coordinator (Site Public Contact) · 212-639-7592
    Contact: Principal Investigator (David H. Aggen)
  • NYU Langone Hospital - Long Island, Mineola, New York, United States

  • Mount Sinai Chelsea, New York, New York, United States

    Contact: Study coordinator (Site Public Contact) · CCTO@mssm.edu · 212-824-7309
    Contact: Principal Investigator (Matthew D. Galsky)
  • Laura and Isaac Perlmutter Cancer Center at NYU Langone, New York, New York, United States

    Contact: Study coordinator (Site Public Contact) · CancerTrials@nyulangone.org
    Contact: Principal Investigator (Katie S. Murray)
  • Mount Sinai Hospital, New York, New York, United States

    Contact: Study coordinator (Site Public Contact) · CCTO@mssm.edu · 212-824-7309
    Contact: Principal Investigator (Matthew D. Galsky)
  • Memorial Sloan Kettering Cancer Center, New York, New York, United States

    Contact: Study coordinator (Site Public Contact) · 212-639-7592
    Contact: Principal Investigator (David H. Aggen)
  • NYP/Weill Cornell Medical Center, New York, New York, United States

    Contact: Study coordinator (Site Public Contact) · 212-746-1848
    Contact: Principal Investigator (Cora N. Sternberg)
  • Rochester General Hospital, Rochester, New York, United States

    Contact: Study coordinator (Site Public Contact) · tia.derosa@rochestergeneral.org · 585-922-3536
    Contact: Principal Investigator (Maria M. Sbenghe)
  • Unity Park Ridge Campus, Rochester, New York, United States

    Contact: Study coordinator (Site Public Contact) · protocols@AllianceNCTN.org · 773-702-9171
    Contact: Principal Investigator (Maria M. Sbenghe)
  • University of Rochester, Rochester, New York, United States

    Contact: Study coordinator (Site Public Contact) · 585-275-5830
    Contact: Principal Investigator (Brendan J. Guercio)
  • Stony Brook University Medical Center, Stony Brook, New York, United States

    Contact: Study coordinator (Site Public Contact) · 800-862-2215
    Contact: Principal Investigator (Judy Huang)
  • Montefiore Medical Center-Einstein Campus, The Bronx, New York, United States

    Contact: Study coordinator (Site Public Contact) · eskwak@montefiore.org · 718-379-6866
    Contact: Principal Investigator (Benjamin A. Gartrell)
  • Memorial Sloan Kettering Nassau, Uniondale, New York, United States

    Contact: Study coordinator (Site Public Contact) · 212-639-7592
    Contact: Principal Investigator (David H. Aggen)
  • Wilmot Cancer Institute at Webster, Webster, New York, United States

    Contact: Study coordinator (Site Public Contact) · WCICTOresearch@urmc.rochester.edu
    Contact: Principal Investigator (Brendan J. Guercio)
  • Atrium Health Stanly/LCI-Albemarle, Albemarle, North Carolina, United States

    Contact: Study coordinator (Site Public Contact) · 800-804-9376
    Contact: Principal Investigator (Landon C. Brown)
  • Duke Cancer Center Cary, Cary, North Carolina, United States

    Contact: Study coordinator (Site Public Contact) · NCTNStudyTeam@dm.duke.edu
    Contact: Principal Investigator (Hannah D. McManus)
  • UNC Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina, United States

    Contact: Study coordinator (Site Public Contact) · cancerclinicaltrials@med.unc.edu · 877-668-0683
    Contact: Principal Investigator (Matthew I. Milowsky)
  • Carolinas Medical Center/Levine Cancer Institute, Charlotte, North Carolina, United States

    Contact: Study coordinator (Site Public Contact) · 800-804-9376
    Contact: Principal Investigator (Landon C. Brown)
  • Atrium Health Pineville/LCI-Pineville, Charlotte, North Carolina, United States

    Contact: Study coordinator (Site Public Contact) · 980-442-2000
    Contact: Principal Investigator (Landon C. Brown)
  • Levine Cancer Institute-SouthPark, Charlotte, North Carolina, United States

    Contact: Study coordinator (Site Public Contact) · 980-442-2000
    Contact: Principal Investigator (Landon C. Brown)
  • Atrium Health University City/LCI-University, Charlotte, North Carolina, United States

    Contact: Study coordinator (Site Public Contact) · 800-804-9376
    Contact: Principal Investigator (Landon C. Brown)
  • Levine Cancer Institute-Ballantyne, Charlotte, North Carolina, United States

    Contact: Study coordinator (Site Public Contact) · 800-804-9376
    Contact: Principal Investigator (Landon C. Brown)
  • Wake Forest University at Clemmons, Clemmons, North Carolina, United States

    Contact: Study coordinator (Site Public Contact) · 888-716-9259
    Contact: Principal Investigator (Michael McCormack)
  • Atrium Health Cabarrus/LCI-Concord, Concord, North Carolina, United States

    Contact: Study coordinator (Site Public Contact) · 800-804-9376
    Contact: Principal Investigator (Landon C. Brown)
  • Duke University Medical Center, Durham, North Carolina, United States

    Contact: Study coordinator (Site Public Contact) · 888-275-3853
    Contact: Principal Investigator (Hannah D. McManus)
  • Duke Cancer Center Southpoint, Durham, North Carolina, United States

    Contact: Study coordinator (Site Public Contact) · NCTNStudyTeam@dm.duke.edu
    Contact: Principal Investigator (Hannah D. McManus)
  • Levine Cancer Institute - Rutherford, Forest City, North Carolina, United States

    Contact: Study coordinator (Site Public Contact) · 800-804-9376
    Contact: Principal Investigator (Landon C. Brown)
  • Levine Cancer Institute-Gaston, Gastonia, North Carolina, United States

    Contact: Study coordinator (Site Public Contact) · 800-804-9376
    Contact: Principal Investigator (Landon C. Brown)
  • Levine Cancer Institute - Huntersville, Huntersville, North Carolina, United States

    Contact: Study coordinator (Site Public Contact) · 980-442-2000
    Contact: Principal Investigator (Landon C. Brown)
  • Atrium Health Lincoln/LCI-Lincolnton, Lincolnton, North Carolina, United States

    Contact: Study coordinator (Site Public Contact) · 800-804-9376
    Contact: Principal Investigator (Landon C. Brown)
  • Levine Cancer Institute - Union West, Matthews, North Carolina, United States

    Contact: Study coordinator (Site Public Contact) · 980-442-0600
    Contact: Principal Investigator (Landon C. Brown)
  • Atrium Health Union/LCI-Union, Monroe, North Carolina, United States

    Contact: Study coordinator (Site Public Contact) · 980-442-2000
    Contact: Principal Investigator (Landon C. Brown)
  • FirstHealth of the Carolinas-Moore Regional Hospital, Pinehurst, North Carolina, United States

    Contact: Study coordinator (Site Public Contact) · jcwilliams@firsthealth.org · 910-715-3500
    Contact: Principal Investigator (Charles S. Kuzma)
  • Duke Cancer Center Raleigh, Raleigh, North Carolina, United States

    Contact: Study coordinator (Site Public Contact) · NCTNStudyTeam@dm.duke.edu
    Contact: Principal Investigator (Hannah D. McManus)
  • Atrium Health Cleveland/LCI-Cleveland, Shelby, North Carolina, United States

    Contact: Study coordinator (Site Public Contact) · 800-804-9376
    Contact: Principal Investigator (Landon C. Brown)
  • Wake Forest University Health Sciences, Winston-Salem, North Carolina, United States

    Contact: Study coordinator (Site Public Contact) · 336-713-6771
    Contact: Principal Investigator (Michael McCormack)
  • Sanford Bismarck Medical Center, Bismarck, North Dakota, United States

    Contact: Study coordinator (Site Public Contact) · OncologyClinicalTrialsFargo@sanfordhealth.org · 701-323-5760
    Contact: Principal Investigator (Daniel Almquist)
  • Sanford Broadway Medical Center, Fargo, North Dakota, United States

    Contact: Study coordinator (Site Public Contact) · OncologyClinicalTrialsFargo@sanfordhealth.org · 701-323-5760
    Contact: Principal Investigator (Daniel Almquist)
  • Sanford Roger Maris Cancer Center, Fargo, North Dakota, United States

    Contact: Study coordinator (Site Public Contact) · OncologyClinicalTrialsFargo@sanfordhealth.org · 701-234-6161
    Contact: Principal Investigator (Daniel Almquist)
  • OhioHealth O'Bleness Hospital, Athens, Ohio, United States

  • University of Cincinnati Cancer Center-UC Medical Center, Cincinnati, Ohio, United States

    Contact: Study coordinator (Site Public Contact) · cancer@uchealth.com · 513-584-7698
    Contact: Principal Investigator (Robert A. Franklin)
  • Ohio State University Comprehensive Cancer Center, Columbus, Ohio, United States

    Contact: Study coordinator (Site Public Contact) · Jamesline@osumc.edu · 800-293-5066
    Contact: Principal Investigator (Lingbin Meng)
  • Columbus Oncology and Hematology Associates Inc, Columbus, Ohio, United States

  • Riverside Methodist Hospital, Columbus, Ohio, United States

  • Grant Medical Center, Columbus, Ohio, United States

  • Doctors Hospital, Columbus, Ohio, United States

  • Delaware Health Center-Grady Cancer Center, Delaware, Ohio, United States

  • Grady Memorial Hospital, Delaware, Ohio, United States

  • Columbus Oncology and Hematology Associates, Dublin, Ohio, United States

  • Dublin Methodist Hospital, Dublin, Ohio, United States

  • OhioHealth Mansfield Hospital, Mansfield, Ohio, United States

  • OhioHealth Marion General Hospital, Marion, Ohio, United States

  • OhioHealth Pickerington Methodist Hospital, Pickerington, Ohio, United States

  • ProMedica Flower Hospital, Sylvania, Ohio, United States

    Contact: Study coordinator (Site Public Contact) · PCIOncResearch@promedica.org · 419-824-1842
    Contact: Principal Investigator (Jeffrey H. Muler)
  • University of Cincinnati Cancer Center-West Chester, West Chester, Ohio, United States

    Contact: Study coordinator (Site Public Contact) · cancer@uchealth.com · 513-584-7698
    Contact: Principal Investigator (Robert A. Franklin)
  • OhioHealth Westerville Medical Campus/Westerville Cancer Center, Westerville, Ohio, United States

  • Cancer Centers of Southwest Oklahoma Research, Lawton, Oklahoma, United States

    Contact: Study coordinator (Site Public Contact) · 877-231-4440
    Contact: Principal Investigator (Adanma Anji Ayanambakkam Attanathi)
  • University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, United States

    Contact: Study coordinator (Site Public Contact) · ou-clinical-trials@ouhsc.edu · 405-271-8777
    Contact: Principal Investigator (Adanma Anji Ayanambakkam Attanathi)
  • Oklahoma Cancer Specialists and Research Institute-Tulsa, Tulsa, Oklahoma, United States

  • Saint Alphonsus Cancer Care Center-Ontario, Ontario, Oregon, United States

    Contact: Study coordinator (Site Public Contact) · mccinfo@mtcancer.org · 406-969-6060
    Contact: Principal Investigator (Elie G. Dib)
  • Providence Willamette Falls Medical Center, Oregon City, Oregon, United States

    Contact: Study coordinator (Site Public Contact) · CanRsrchStudies@providence.org · 503-215-2614
    Contact: Principal Investigator (Alison K. Conlin)
  • Providence Portland Medical Center, Portland, Oregon, United States

    Contact: Study coordinator (Site Public Contact) · CanRsrchStudies@providence.org · 503-215-2614
    Contact: Principal Investigator (Alison K. Conlin)
  • Providence Saint Vincent Medical Center, Portland, Oregon, United States

    Contact: Study coordinator (Site Public Contact) · CanRsrchStudies@providence.org · 503-215-2614
    Contact: Principal Investigator (Alison K. Conlin)
  • Oregon Health and Science University, Portland, Oregon, United States

    Contact: Study coordinator (Site Public Contact) · trials@ohsu.edu · 503-494-1080
    Contact: Principal Investigator (Ronald Ng)
  • Lehigh Valley Hospital-Cedar Crest, Allentown, Pennsylvania, United States

    Contact: Study coordinator (Site Public Contact) · Morgan_M.Horton@lvhn.org · 610-402-9543
    Contact: Principal Investigator (Elie G. Dib)
  • UPMC Altoona, Altoona, Pennsylvania, United States

    Contact: Study coordinator (Site Public Contact) · protocols@AllianceNCTN.org · 773-702-9171
    Contact: Principal Investigator (Leonard J. Appleman)
  • UPMC-Heritage Valley Health System Beaver, Beaver, Pennsylvania, United States

    Contact: Study coordinator (Site Public Contact) · haneydl@upmc.edu · 412-389-5208
    Contact: Principal Investigator (Leonard J. Appleman)
  • Lehigh Valley Hospital - Muhlenberg, Bethlehem, Pennsylvania, United States

    Contact: Study coordinator (Site Public Contact) · Morgan_M.Horton@lvhn.org · 610-402-9543
    Contact: Principal Investigator (Elie G. Dib)
  • Pocono Medical Center, East Stroudsburg, Pennsylvania, United States

    Contact: Study coordinator (Site Public Contact) · Morgan_M.Horton@lvhn.org · 610-402-9543
    Contact: Principal Investigator (Elie G. Dib)
  • UPMC Hillman Cancer Center Erie, Erie, Pennsylvania, United States

    Contact: Study coordinator (Site Public Contact) · ClinicalResearchServices@upmc.edu · 412-864-7716
    Contact: Principal Investigator (Leonard J. Appleman)
  • UPMC Cancer Centers - Arnold Palmer Pavilion, Greensburg, Pennsylvania, United States

    Contact: Study coordinator (Site Public Contact) · 724-838-1900
    Contact: Principal Investigator (Leonard J. Appleman)
  • UPMC Pinnacle Cancer Center/Community Osteopathic Campus, Harrisburg, Pennsylvania, United States

    Contact: Study coordinator (Site Public Contact) · klitchfield@PINNACLEHEALTH.org · 717-724-6765
    Contact: Principal Investigator (Leonard J. Appleman)
  • Lancaster General Ann B Barshinger Cancer Institute, Lancaster, Pennsylvania, United States

  • UPMC Hillman Cancer Center at Rocco And Nancy Ortenzio Cancer Pavilion, Mechanicsburg, Pennsylvania, United States

    Contact: Study coordinator (Site Public Contact) · haneydl@upmc.edu · 412-389-5208
    Contact: Principal Investigator (Leonard J. Appleman)
  • UPMC Hillman Cancer Center - Monroeville, Monroeville, Pennsylvania, United States

    Contact: Study coordinator (Site Public Contact) · ClinicalResearchServices@upmc.edu · 412-864-7716
    Contact: Principal Investigator (Leonard J. Appleman)
  • University of Pennsylvania/Abramson Cancer Center, Philadelphia, Pennsylvania, United States

  • Thomas Jefferson University Hospital, Philadelphia, Pennsylvania, United States

    Contact: Study coordinator (Site Public Contact) · ONCTrialNow@jefferson.edu · 215-600-9151
    Contact: Principal Investigator (Patrick Mille)
  • Jefferson Torresdale Hospital, Philadelphia, Pennsylvania, United States

    Contact: Study coordinator (Site Public Contact) · ONCTrialNow@jefferson.edu · 215-600-9151
    Contact: Principal Investigator (Patrick Mille)
  • UPMC-Saint Margaret, Pittsburgh, Pennsylvania, United States

    Contact: Study coordinator (Site Public Contact) · 412-784-4900
    Contact: Principal Investigator (Leonard J. Appleman)
  • University of Pittsburgh Cancer Institute (UPCI), Pittsburgh, Pennsylvania, United States

    Contact: Study coordinator (Site Public Contact) · 412-647-8073
    Contact: Principal Investigator (Leonard J. Appleman)
  • UPMC-Passavant Hospital, Pittsburgh, Pennsylvania, United States

    Contact: Study coordinator (Site Public Contact) · 412-367-6454
    Contact: Principal Investigator (Leonard J. Appleman)
  • UPMC-Saint Clair Hospital Cancer Center, Pittsburgh, Pennsylvania, United States

    Contact: Study coordinator (Site Public Contact) · 412-502-3920
    Contact: Principal Investigator (Leonard J. Appleman)
  • Reading Hospital, West Reading, Pennsylvania, United States

    Contact: Study coordinator (Site Public Contact) · 610-988-9323
    Contact: Principal Investigator (Terrence P. Cescon)
  • Asplundh Cancer Pavilion, Willow Grove, Pennsylvania, United States

    Contact: Study coordinator (Site Public Contact) · ONCTrialNow@jefferson.edu · 215-600-9151
    Contact: Principal Investigator (Patrick Mille)
  • Smilow Cancer Hospital Care Center - Westerly, Westerly, Rhode Island, United States

    Contact: Study coordinator (Site Public Contact) · canceranswers@yale.edu · 203-785-5702
    Contact: Principal Investigator (Joseph W. Kim)
  • AnMed Health Cancer Center, Anderson, South Carolina, United States

    Contact: Study coordinator (Site Public Contact) · rhonda.ballew@anmedhealth.org · 864-512-4651
    Contact: Principal Investigator (Jay B. Nayak)
  • Prisma Health Cancer Institute - Spartanburg, Boiling Springs, South Carolina, United States

    Contact: Study coordinator (Site Public Contact) · Kim.Williams3@prismahealth.org · 864-522-4317
    Contact: Principal Investigator (Ki Y. Chung)
  • Medical University of South Carolina, Charleston, South Carolina, United States

    Contact: Study coordinator (Site Public Contact) · hcc-clinical-trials@musc.edu · 843-792-9321
    Contact: Principal Investigator (Theodore S. Gourdin)
  • Prisma Health Cancer Institute - Easley, Easley, South Carolina, United States

    Contact: Study coordinator (Site Public Contact) · Kim.Williams3@prismahealth.org · 864-522-4317
    Contact: Principal Investigator (Ki Y. Chung)
  • Gibbs Cancer Center-Gaffney, Gaffney, South Carolina, United States

    Contact: Study coordinator (Site Public Contact) · kmertz-rivera@gibbscc.org · 864-560-6104
    Contact: Principal Investigator (Michael Humeniuk)
  • Prisma Health Cancer Institute - Butternut, Greenville, South Carolina, United States

    Contact: Study coordinator (Site Public Contact) · Kim.Williams3@prismahealth.org · 864-522-4317
    Contact: Principal Investigator (Ki Y. Chung)
  • Prisma Health Cancer Institute - Faris, Greenville, South Carolina, United States

    Contact: Study coordinator (Site Public Contact) · Kim.Williams3@prismahealth.org · 864-522-4317
    Contact: Principal Investigator (Ki Y. Chung)
  • Prisma Health Greenville Memorial Hospital, Greenville, South Carolina, United States

    Contact: Study coordinator (Site Public Contact) · Kim.Williams3@prismahealth.org · 864-522-4317
    Contact: Principal Investigator (Ki Y. Chung)
  • Prisma Health Cancer Institute - Eastside, Greenville, South Carolina, United States

    Contact: Study coordinator (Site Public Contact) · Kim.Williams3@prismahealth.org · 864-522-4317
    Contact: Principal Investigator (Ki Y. Chung)
  • Prisma Health Cancer Institute - Greer, Greer, South Carolina, United States

    Contact: Study coordinator (Site Public Contact) · Kim.Williams3@prismahealth.org · 864-522-4317
    Contact: Principal Investigator (Ki Y. Chung)
  • Gibbs Cancer Center-Pelham, Greer, South Carolina, United States

    Contact: Study coordinator (Site Public Contact) · kmertz-rivera@gibbscc.org · 864-560-6104
    Contact: Principal Investigator (Michael Humeniuk)
  • Levine Cancer Institute-Rock Hill, Rock Hill, South Carolina, United States

    Contact: Study coordinator (Site Public Contact) · 800-804-9376
    Contact: Principal Investigator (Landon C. Brown)
  • Prisma Health Cancer Institute - Seneca, Seneca, South Carolina, United States

    Contact: Study coordinator (Site Public Contact) · Kim.Williams3@prismahealth.org · 864-522-4317
    Contact: Principal Investigator (Ki Y. Chung)
  • Spartanburg Medical Center, Spartanburg, South Carolina, United States

    Contact: Study coordinator (Site Public Contact) · kmertz-rivera@gibbscc.org · 864-560-6104
    Contact: Principal Investigator (Michael Humeniuk)
  • SMC Center for Hematology Oncology Union, Union, South Carolina, United States

    Contact: Study coordinator (Site Public Contact) · kmertz-rivera@gibbscc.org · 864-560-6104
    Contact: Principal Investigator (Michael Humeniuk)
  • Sanford Cancer Center Oncology Clinic, Sioux Falls, South Dakota, United States

    Contact: Study coordinator (Site Public Contact) · OncologyClinicTrialsSF@sanfordhealth.org · 605-312-3320
    Contact: Principal Investigator (Daniel Almquist)
  • Sanford USD Medical Center - Sioux Falls, Sioux Falls, South Dakota, United States

    Contact: Study coordinator (Site Public Contact) · OncologyClinicalTrialsSF@SanfordHealth.org · 605-312-3320
    Contact: Principal Investigator (Daniel Almquist)
  • The West Clinic - Wolf River, Germantown, Tennessee, United States

  • Vanderbilt University/Ingram Cancer Center, Nashville, Tennessee, United States

    Contact: Study coordinator (Site Public Contact) · 800-811-8480
    Contact: Principal Investigator (Kerry R. Schaffer)
  • UT Southwestern Simmons Cancer Center - RedBird, Dallas, Texas, United States

    Contact: Study coordinator (Site Public Contact) · canceranswerline@utsouthwestern.edu · 214-648-7097
    Contact: Principal Investigator (Tian Zhang)
  • UT Southwestern/Simmons Cancer Center-Dallas, Dallas, Texas, United States

    Contact: Study coordinator (Site Public Contact) · canceranswerline@UTSouthwestern.edu · 214-648-7097
    Contact: Principal Investigator (Tian Zhang)
  • UT Southwestern/Simmons Cancer Center-Fort Worth, Fort Worth, Texas, United States

    Contact: Study coordinator (Site Public Contact) · canceranswerline@UTSouthwestern.edu · 214-648-7097
    Contact: Principal Investigator (Tian Zhang)
  • Lyndon Baines Johnson General Hospital, Houston, Texas, United States

    Contact: Study coordinator (Site Public Contact) · 713-566-5000
    Contact: Principal Investigator (Debanjan Pain)
  • Baylor College of Medicine/Dan L Duncan Comprehensive Cancer Center, Houston, Texas, United States

    Contact: Study coordinator (Site Public Contact) · burton@bcm.edu · 713-798-1354
    Contact: Principal Investigator (Aihua E. Yen)
  • Ben Taub General Hospital, Houston, Texas, United States

    Contact: Study coordinator (Site Public Contact) · 713-873-2000
    Contact: Principal Investigator (Aihua E. Yen)
  • Michael E DeBakey VA Medical Center, Houston, Texas, United States

    Contact: Study coordinator (Site Public Contact) · 800-553-2278
    Contact: Principal Investigator (Aihua E. Yen)
  • UT Southwestern Clinical Center at Richardson/Plano, Richardson, Texas, United States

    Contact: Study coordinator (Site Public Contact) · Suzanne.cole@utsouthwestern.edu · 972-669-7044
    Contact: Principal Investigator (Tian Zhang)
  • Huntsman Cancer Institute/University of Utah, Salt Lake City, Utah, United States

    Contact: Study coordinator (Site Public Contact) · cancerinfo@hci.utah.edu · 888-424-2100
    Contact: Principal Investigator (Bogdana Schmidt)
  • Central Vermont Medical Center/National Life Cancer Treatment, Berlin Corners, Vermont, United States

    Contact: Study coordinator (Site Public Contact) · 802-225-5400
    Contact: Principal Investigator (Steven Ades)
  • University of Vermont Medical Center, Burlington, Vermont, United States

    Contact: Study coordinator (Site Public Contact) · rpo@uvm.edu · 802-656-4101
    Contact: Principal Investigator (Steven Ades)
  • University of Vermont and State Agricultural College, Burlington, Vermont, United States

    Contact: Study coordinator (Site Public Contact) · rpo@uvm.edu · 802-656-8990
    Contact: Principal Investigator (Steven Ades)
  • University of Virginia Cancer Center, Charlottesville, Virginia, United States

    Contact: Study coordinator (Site Public Contact) · uvacancertrials@hscmail.mcc.virginia.edu · 434-243-6303
    Contact: Principal Investigator (Paul V. Viscuse)
  • Bon Secours Memorial Regional Medical Center, Mechanicsville, Virginia, United States

    Contact: Study coordinator (Site Public Contact) · anne_carmellat@bshsi.org · 804-893-8978
    Contact: Principal Investigator (Joseph D. Pennington)
  • Bon Secours Saint Francis Medical Center, Midlothian, Virginia, United States

    Contact: Study coordinator (Site Public Contact) · anne_carmellat@bshsi.org · 804-893-8978
    Contact: Principal Investigator (Joseph D. Pennington)
  • Bon Secours Richmond Community Hospital, Richmond, Virginia, United States

    Contact: Study coordinator (Site Public Contact) · anne_carmellat@bshsi.org · 804-893-8978
    Contact: Principal Investigator (Joseph D. Pennington)
  • Bon Secours Saint Mary's Hospital, Richmond, Virginia, United States

    Contact: Study coordinator (Site Public Contact) · anne_carmellat@bshsi.org · 804-893-8978
    Contact: Principal Investigator (Joseph D. Pennington)
  • VCU Massey Cancer Center at Stony Point, Richmond, Virginia, United States

    Contact: Study coordinator (Site Public Contact) · ctoclinops@vcu.edu
    Contact: Principal Investigator (John Melson)
  • VCU Massey Comprehensive Cancer Center, Richmond, Virginia, United States

    Contact: Study coordinator (Site Public Contact) · CTOclinops@vcu.edu · 804-628-6430
    Contact: Principal Investigator (John Melson)
  • VCU Community Memorial Health Center, South Hill, Virginia, United States

    Contact: Study coordinator (Site Public Contact) · nemer.elmouallem@vcuhealth.org
    Contact: Principal Investigator (John Melson)
  • Virginia Mason Medical Center, Seattle, Washington, United States

    Contact: Study coordinator (Site Public Contact) · cancerresearch@virginiamason.org · 206-287-6275
    Contact: Principal Investigator (Huong T. Pham)
  • West Virginia University Charleston Division, Charleston, West Virginia, United States

    Contact: Study coordinator (Site Public Contact) · 304-388-9944
    Contact: Principal Investigator (Kok Hoe Chan)
  • West Virginia University Healthcare, Morgantown, West Virginia, United States

    Contact: Study coordinator (Site Public Contact) · cancertrialsinfo@hsc.wvu.edu · 304-293-7374
    Contact: Principal Investigator (Raheel S. Siddiqui)
  • ThedaCare Regional Cancer Center, Appleton, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · ResearchDept@thedacare.org · 920-364-3604
    Contact: Principal Investigator (Joyce Philip)
  • Aurora Saint Luke's South Shore, Cudahy, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · ncorp@aurora.org · 414-302-2304
    Contact: Principal Investigator (Adam P. Siegel)
  • Marshfield Medical Center-EC Cancer Center, Eau Claire, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · oncology.clinical.trials@marshfieldresearch.org · 800-782-8581
    Contact: Principal Investigator (Michael Husak)
  • Aurora Cancer Care-Grafton, Grafton, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · ncorp@aurora.org · 414-302-2304
    Contact: Principal Investigator (Adam P. Siegel)
  • Saint Vincent Hospital Cancer Center Green Bay, Green Bay, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · WI_research_admin@hshs.org · 920-433-8889
    Contact: Principal Investigator (Anthony J. Jaslowski)
  • Saint Vincent Hospital Cancer Center at Saint Mary's, Green Bay, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · wi_research_admin@hshs.org · 920-433-8889
    Contact: Principal Investigator (Anthony J. Jaslowski)
  • Aurora BayCare Medical Center, Green Bay, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · ncorp@aurora.org · 414-302-2304
    Contact: Principal Investigator (Adam P. Siegel)
  • University of Wisconsin Carbone Cancer Center - Eastpark Medical Center, Madison, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · clinicaltrials@cancer.wisc.edu · 800-622-8922
    Contact: Principal Investigator (Christos Kyriakopoulos)
  • University of Wisconsin Carbone Cancer Center - University Hospital, Madison, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · clinicaltrials@cancer.wisc.edu · 800-622-8922
    Contact: Principal Investigator (Christos Kyriakopoulos)
  • Aurora Bay Area Medical Group-Marinette, Marinette, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · ncorp@aurora.org · 414-302-2304
    Contact: Principal Investigator (Adam P. Siegel)
  • Marshfield Medical Center-Marshfield, Marshfield, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · oncology.clinical.trials@marshfieldresearch.org · 800-782-8581
    Contact: Principal Investigator (Michael Husak)
  • Aurora Saint Luke's Medical Center, Milwaukee, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · ncorp@aurora.org · 414-302-2304
    Contact: Principal Investigator (Adam P. Siegel)
  • Medical College of Wisconsin, Milwaukee, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · 414-805-3666
    Contact: Principal Investigator (Kathryn A. Bylow)
  • Aurora Sinai Medical Center, Milwaukee, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · ncorp@aurora.org · 414-302-2304
    Contact: Principal Investigator (Adam P. Siegel)
  • ProHealth D N Greenwald Center, Mukwonago, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · research.institute@phci.org
    Contact: Principal Investigator (Timothy R. Wassenaar)
  • ProHealth Oconomowoc Memorial Hospital, Oconomowoc, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · 262-928-7878
    Contact: Principal Investigator (Timothy R. Wassenaar)
  • Saint Vincent Hospital Cancer Center at Oconto Falls, Oconto Falls, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · WI_research_admin@hshs.org · 920-433-8889
    Contact: Principal Investigator (Anthony J. Jaslowski)
  • Vince Lombardi Cancer Clinic - Oshkosh, Oshkosh, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · ncorp@aurora.org · 414-302-2304
    Contact: Principal Investigator (Adam P. Siegel)
  • Saint Vincent Hospital Cancer Center at Sheboygan, Sheboygan, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · wi_research_admin@hshs.org · 920-433-8889
    Contact: Principal Investigator (Anthony J. Jaslowski)
  • Vince Lombardi Cancer Clinic-Sheboygan, Sheboygan, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · ncorp@aurora.org · 414-302-2304
    Contact: Principal Investigator (Adam P. Siegel)
  • Marshfield Medical Center-River Region at Stevens Point, Stevens Point, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · oncology.clinical.trials@marshfieldresearch.org · 800-782-8581
    Contact: Principal Investigator (Michael Husak)
  • Saint Vincent Hospital Cancer Center at Sturgeon Bay, Sturgeon Bay, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · wi_research_admin@hshs.org · 920-433-8889
    Contact: Principal Investigator (Anthony J. Jaslowski)
  • Aurora Medical Center in Summit, Summit, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · ncorp@aurora.org · 414-302-2304
    Contact: Principal Investigator (Adam P. Siegel)
  • Vince Lombardi Cancer Clinic-Two Rivers, Two Rivers, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · ncorp@aurora.org · 414-302-2304
    Contact: Principal Investigator (Adam P. Siegel)
  • ProHealth Waukesha Memorial Hospital, Waukesha, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · 262-928-7632
    Contact: Principal Investigator (Timothy R. Wassenaar)
  • UW Cancer Center at ProHealth Care, Waukesha, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · Chanda.miller@phci.org · 262-928-5539
    Contact: Principal Investigator (Timothy R. Wassenaar)
  • Aurora Cancer Care-Milwaukee West, Wauwatosa, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · ncorp@aurora.org · 414-302-2304
    Contact: Principal Investigator (Adam P. Siegel)
  • Aurora West Allis Medical Center, West Allis, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · ncorp@aurora.org · 414-302-2304
    Contact: Principal Investigator (Adam P. Siegel)
  • Marshfield Medical Center - Weston, Weston, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · oncology.clinical.trials@marshfieldresearch.org · 800-782-8581
    Contact: Principal Investigator (Michael Husak)
  • Arthur J E Child Comprehensive Cancer Centre, Calgary, Alberta, Canada

    Contact: Study coordinator (Site Public Contact) · ctsucontact@westat.com · 888-823-5923
    Contact: Principal Investigator (Nimira S. Alimohamed)
  • Cross Cancer Institute, Edmonton, Alberta, Canada

    Contact: Study coordinator (Site Public Contact) · 780-432-8500
    Contact: Principal Investigator (Scott A. North)
  • BCCA-Vancouver Cancer Centre, Vancouver, British Columbia, Canada

    Contact: Study coordinator (Site Public Contact) · 888-939-3333
    Contact: Principal Investigator (Bernie (Bernhard) J. Eigl)
  • Waterloo Regional Health Network, Kitchener, Ontario, Canada

    Contact: Study coordinator (Site Public Contact) · research@wrhn.ca · 519-749-4370
    Contact: Principal Investigator (Anupam Batra)
  • London Regional Cancer Program, London, Ontario, Canada

    Contact: Study coordinator (Site Public Contact) · 519-685-8600
    Contact: Principal Investigator (Melissa Huynh)
  • Ottawa Hospital and Cancer Center-General Campus, Ottawa, Ontario, Canada

    Contact: Study coordinator (Site Public Contact) · 613-761-4395
    Contact: Principal Investigator (Ana-Alicia Beltran-Bless)
  • Odette Cancer Centre- Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada

    Contact: Study coordinator (Site Public Contact) · 416-480-5000
    Contact: Principal Investigator (Susanna Y. Cheng)
  • University Health Network-Princess Margaret Hospital, Toronto, Ontario, Canada

    Contact: Study coordinator (Site Public Contact) · clinical.trials@uhn.on.ca · 416-946-4501
    Contact: Principal Investigator (Srikala S. Sridhar)
Study leads
  • Matthew D Galsky

    Principal Investigator

    Alliance for Clinical Trials in Oncology